Abbott has announced late-breaking, 12-month data from the global FlexPulse investigational device exemption (IDE) study that show favourable safety and effectiveness outcomes for its...
Early electrocardiogram (ECG) monitoring initiated in the emergency department (ED) has the potential to transform the care of thousands of patients who attend the...
Edoxaban—an oral anticoagulant medication—failed to reduce stroke or systemic embolism but did increase major bleeding in high-risk patients with atrial fibrillation (AF) who had...
While younger patients appeared to benefit, implantable cardioverter-defibrillators (ICDs) did not improve the primary endpoint overall in the CMR GUIDE trial, according to new...
Targeted placement of a left ventricular lead does not improve outcomes in patients with heart failure undergoing cardiac resynchronisation therapy (CRT), according to results presented...
Catheter ablation for atrial fibrillation (AF) did not significantly improve AF-related quality of life compared with a sham procedure, despite reducing AF recurrence, as...
Routine concomitant closure of the left atrial appendage (LAA) during open-heart surgery should not be considered unless patients are high risk for stroke, results...
Protaryx Medical has announced the successful completion of the first US commercial cases using its US Food and Drug Administration (FDA)-cleared Protaryx transseptal puncture...
Abbott has announced CE marking for the Amulet 360 left atrial appendage (LAA) occluder for reducing risk of stroke in patients with non-valvular atrial...
AliveCor shared today that M-KEEPS—a new prospective cohort study conducted by researchers at the University of Rochester Clinical Cardiovascular Research Center (Rochester, USA)—has been...
Medtronic today announced an expanded CE-mark indication for the Affera mapping and ablation system with Sphere-9 catheter to treat ventricular arrhythmias, including ventricular tachycardia...
Haemonetics Corporation has announced the publication of a study in the open-access journal Heart Rhythm O2 providing new evidence supporting the safety and efficacy...
This advertorial is sponsored by Boston Scientific.
Following the presentation of new data from the AVANT GUARD pivotal trial at the 2026 Heart Rhythm Society (HRS) annual meeting (23–26...
Boston Scientific has announced that it has initiated the FARADIGM clinical trial—a global single-arm investigational device exemption (IDE) study evaluating the safety and effectiveness of...
ElectroWire Medical has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its LightningWire transseptal puncture system, which is...
Six leading US healthcare societies have jointly endorsed an expert consensus statement, calling for cath lab professionals to have greater protection from preventable radiation...
Stereotaxis has announced that it has completed its previously announced acquisition of Robocath—an innovator of robotic technologies for interventional cardiology and neurointerventions.
As per a press...
Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has approved the dual-energy ThermoCool SmartTouch SF platform (DE STSF)—an...
AtaCor Medical announced today the enrolment of the first patient in the company's ALARION-EV study, which is evaluating an investigational, next-generation parasternal extravascular implantable...
A new international expert consensus document has attempted to refine how heart failure is identified and classified, aiming to improve prevention, diagnosis and management of the...
Johnson & Johnson (J&J) today announced the commercial launch of the dual-energy ThermoCool SmartTouch SF (DE STSF) platform in Europe.
The platform combines the dual-energy...
In a prespecified sub-analysis of the CHAMPION-AF trial, investigators found similar rates of stroke, systemic embolism and cardiovascular death, regardless of age, among atrial...
Tempus has announced the publication of successful multi-site validation of its artificial intelligence (AI)-enabled electrocardiogram (ECG) software, which received US Food and Drug Administration...
Medtronic has announced strategic investments in two privately held companies focused on the development of intracardiac echocardiography (ICE) catheter technologies, which provide real-time, high-resolution...
Accurkardia has announced that it has been granted US patent number 12,620,488 for the company's proprietary machine learning-based system for identifying cardiac amyloidosis from...
Rhythm AI, developer of the Star Apollo mapping software, has announced the appointment of Mike Dineen as chief executive officer (CEO). Dineen brings more than 30...
Biotronik announced today the first European implantations of its LivIQ leadless pacemaker system as part of the BIO-LivIQ study—a prospective, multicentre study that will...
SQ Innovation has announced topline results from the SUBCUT HF II trial of its Lasix ONYU product, a novel subcutaneous formulation of furosemide for...
Results from the CRAFT randomised controlled trial (RCT)—presented this week at the European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands)—show that targeting a...
A new study presented earlier today at the 2026 European Stroke Organisation Conference (ESOC; 6–8 May, Maastricht, Netherlands) suggests that both very low and...
Johnson & Johnson (J&J) recently announced it has entered into a definitive agreement to acquire Atraverse Medical—a company attempting to pioneer next-generation left-heart access...
iRhythm Holdings has announced results from two real-world retrospective analyses in post-ablation and pregnancy patient populations presented at the 2026 Heart Rhythm Society (HRS)...
A new analysis from the NOAH-AFNET 6 trial has shown that artificial intelligence (AI) can help unlock data from pacemakers to better understand stroke...
New results from a pivotal multicentre trial—FULCRUM-VT—show that ultra-low-temperature ablation (ULTA) may offer a promising new treatment option for patients with ventricular tachycardia (VT)...
A new study examining the accuracy of wearable technologies for capturing irregular heartbeats in children has found that the Apple Watch (Apple) can potentially...
New results from the multicentre CAAD-VT trial show that catheter ablation may reduce ventricular tachycardia (VT) events in patients with ischaemic and non-ischaemic cardiomyopathy....
The Heart Rhythm Society (HRS) has announced the first analysis of its COMPASS initiative, which is evaluating the impact of structured care pathways for...
A new study analysing data from more than 13,000 patients has found that people using the increasingly popular weight-loss drugs known as glucagon-like peptide-1...
A new expert consensus statement published recently in the journal Heart Rhythm details the latest recommendations aimed at guiding clinicians and patients in choosing...
Abbott has announced late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP)...
Johnson & Johnson (J&J) has announced the initiation of the PERSIGMA randomised controlled trial (RCT)—one of the first randomised studies evaluating competitive pulsed field...
Atraverse Medical has announced accelerating market uptake for its Hotwire transseptal access system driven by rapid adoption in catheter labs nationwide and expanding use...
Boston Scientific Corporation has announced data supporting the use of the company's Farapulse pulsed field ablation (PFA) platform and Watchman left atrial appendage closure...
Corify Care has announced a “major clinical milestone” with the publication of two studies in the journals Heart Rhythm and EP Europace validating its...
Medtronic has announced continued momentum regarding its Affera family of technologies for cardiac arrhythmia treatment, including promising data presented at the Heart Rhythm Society...
Haemonetics Corporation has announced the publication of a new study comparing its Vascade MVP XL vascular closure system with the Vascade MVP venous vascular...
AliveCor has announced it has received a CE mark for the Kardia 12L electrocardiogram (ECG) system powered by the company’s KAI 12L artificial intelligence...
Biotronik has announced in a press release that—via a late-breaking trial session at the annual congress of the European Heart Rhythm Association (EHRA; 12–14...
Initial one-year outcomes from the Leadless ARRIVE real-world study—presented at the annual congress of the European Heart Rhythm Association (EHRA; 12–14 April 2026, Paris,...
Stereotaxis has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions.
“Robocath represents a highly...
A late-breaking presentation at the annual congress of the European Heart Rhythm Association (EHRA; 12–14 April 2026, Paris, France) has reaffirmed the safety and...
Implicity has revealed new research presented at the annual congress of the European Heart Rhythm Association (EHRA; 12–14 April 2026, Paris, France) examining why...
Johnson & Johnson (J&J) has announced favourable 12-month interim effectiveness and safety results from VARIPURE—the largest prospective post-market follow-up study evaluating first-time pulsed field ablation...
Protaryx Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its proprietary transseptal puncture device.
According to the company,...
The US Food and Drug Administration (FDA) has reminded more than 2,200 medical product companies and researchers of requirements for them to submit certain...
Left bundle branch area pacing (LBBAP) has been found to be an effective and practical strategy for cardiac resynchronisation therapy (CRT), according to late-breaking...
Heart failure is common in people who have atrial fibrillation (AF) detected during screening, according to a presentation delivered today at the annual congress...
Haemonetics Corporation has announced US Food and Drug Administration (FDA) approval to expand the labelling for the Vascade MVP XL venous vascular closure system...
Johnson & Johnson (J&J) has announced the launch of Varipulse Pro in Europe following CE-mark approval, advancing its pulsed field ablation (PFA) portfolio with...
PaceMate has announced the appointment of Benjamin A Steinberg as its chief medical officer (CMO).
Described by the company as a nationally recognised leader in...
Stereotaxis has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the Synchrony system, which is designed to “digitise...
Omron Healthcare has announced the launch of a randomised controlled trial in collaboration with the University of California San Francisco (UCSF; San Francisco, USA)...
Boston Scientific Corporation announced today that it has received CE-mark approval for its Site Selective Pacing Catheters (SSPC) NXT.
These catheters are designed to support precise and controlled...
The global community of heart rhythm specialists will unite later this month at the annual congress of the European Heart Rhythm Association (EHRA; 12–14...
Results from the multicentre CRT‑NEXT study have shown that CRT‑DX (Biotronik)—a two-lead cardiac resynchronisation therapy defibrillator (CRT-D) system—is as safe and effective as conventional...
For patients with non-valvular atrial fibrillation (AF) who had no contraindications to taking oral anticoagulants, the use of a device to close off the...
Biotronik has announced the initiation of a global pivotal study evaluating its LivIQ leadless pacemaker system—a single‑device solution designed to deliver atrioventricular (AV) synchrony...
Medtronic has received US Food and Drug Administration (FDA) approval for an expanded indication with its OmniaSecure defibrillation lead. Now approved for placement in...
Luma Vision has announced the expansion of its clinical programme with the first patient enrolments in two additional European studies at Na Homolce Hospital...
Nine medical societies are calling for updated safety standards in fluoroscopy laboratories, where clinicians face radiation exposure and orthopaedic injuries from heavy protective equipment.
A report published...
Johnson & Johnson (J&J) has announced the arrival of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation...
Field Medical has announced the appointment of Mark Turco as chief executive officer (CEO), effective immediately.
As per a Field Medical press release, Turco brings...
New research led by scientists from the University of Colorado (CU) Anschutz (Aurora, USA) suggests that staying physically active after heart rhythm treatment may...
Abbott announced recently that its Volt pulsed field ablation (PFA) system is being used in procedures across the UK to treat people with atrial fibrillation...
Biotronik has announced the launch of the new Acticor Sky and Rivacor Sky device family featuring “the world's first” CE mark-approved left bundle branch...
Pulse Biosciences has announced late-breaking clinical data from the nPulse cardiac catheter first-in-human feasibility study, demonstrating the successful treatment of atrial fibrillation (AF) across...
Atraverse Medical has announced the presentation of new clinical and preclinical data at the 2026 AF symposium (5–7 February, Boston, USA), further validating the...
Abbott has announced new clinical data from two late-breaking presentations at the 2026 AF symposium (5–7 February, Boston, USA) that demonstrate the safety and efficacy...
Argá Medtech has announced positive clinical results from the BURST-AF first-in-human trial, demonstrating the safety, effectiveness and durability of its Coherent sine-burst electroporation (CSE)...
Field Medical has announced the presentation of late-breaking clinical trial data from the first-in-human Field PULSE study—which is evaluating the company’s FieldForce ablation system...
Johnson & Johnson (J&J) has announced 12-month pilot-phase data from the OMNY-AF study evaluating its investigational Omnypulse platform for the treatment of symptomatic paroxysmal...
Volta Medical has announced results from the RESTART trial, published in the journal Heart Rhythm, that demonstrate positive outcomes for patients with recurrent atrial fibrillation...
The UK’s National Institute for Health and Care Excellence (NICE) has issued guidance recommending Abbott’s CardioMEMS HF system for remote monitoring of adults with...
An international research consortium has announced the launch of AF-B-STEP, a four-year research project designed to improve how atrial fibrillation (AF) is detected, quantified...
Corify Care has announced a new publication on its proprietary Global Volumetric Mapping technology in Nature Communications Medicine. The company says this technology represents the...
Cathvision has announced “significant clinical and scientific progress” in pulsed field ablation (PFA) with its PFAnalyzer software module, which the company says reinforces its...
Biotronik has today announced the successful first-in-human implantations of its LivIQ leadless pacemaker system as part of the BIO|CONCEPT.LivIQ study—a premarket clinical investigation designed...
CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomised study designed to evaluate the impact of the Barostim neuromodulation device in...
Medtronic has today announced two major milestones relating to the Affera Sphere-360 catheter—the receipt of a CE mark in Europe and completion of the first cases...
Abbott announced this week that it has received a CE mark in Europe for the sensor-enabled TactiFlex Duo ablation catheter to treat patients with...
1. Use of antidepressant medication linked to substantial increase in sudden cardiac death risk
The use of antidepressant (AD) medications has been linked to a...
Medtronic has commercially launched the OmniaSecure defibrillation lead in the USA this week, with the first cases being performed at hospitals across the country.
OmniaSecure...
AliveCor has announced it has received US Food and Drug Administration (FDA) clearance for the next generation of KAI 12L—the artificial intelligence (AI) technology...
YorLabs has announced the successful completion of the first clinical procedure using its US Food and Drug Administration (FDA) 510(k)-cleared intracardiac imaging system.
The procedure...
Abbott has announced a collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy...
Accurkardia has announced US Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of its AccurECG analysis system (v2.0). AccurECG 2.0 builds...
Luma Vision has announced the successful completion of 15 Verafeye-guided persistent atrial fibrillation (AF) ablation procedures conducted as part of a clinical study in...
Stereotaxis has today announced that it has obtained US Food and Drug Administration (FDA) approval for the Magic magnetic interventional ablation catheter—a robotically navigated...
WL Gore & Associates—Gore—has announced that it has entered into a definitive agreement to acquire Conformal Medical, developer of the CLAAS AcuFORM system, a...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Volt pulsed field ablation (PFA) system to treat patients...
Cathvision has announced the appointment of Eric Thepaut as the company’s independent chairman of the board, and the commercial release of version 3.5 of...
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s “groundbreaking” 12-lead electrocardiogram (ECG) synthesis software...
Boston Scientific Corporation has received a CE mark for the Farapoint pulsed field ablation (PFA) catheter, which is intended for use in the treatment...
Atraverse Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) for its fully integrated Hotwire transseptal access system.
The novel system...
VisCardia has secured US$40 million in growth financing to advance the company’s path toward premarket approval (PMA) for its VisONE synchronised diaphragmatic stimulation (SDS)...
Medtronic has announced the recent presentation of results from two late-breaking studies at the 2025 Asia Pacific Heart Rhythm Society (APHRS) Scientific Sessions (12–15...
Catheter ablation—a minimally invasive procedure to correct irregular heart rhythms—may reduce the risk of stroke to such an extent that some patients can discontinue...
Biotronik has announced the enrolment of the first patient in the RESET-AF 3D study, a multicentre clinical study evaluating the Elepulse pulsed field ablation...
For older people with irregular heart rhythms who are at high risk of stroke and bleeding, standard care—including the timely use of anticoagulant blood...
People with atrial fibrillation (AF) and obesity may have fewer episodes of AF after catheter ablation treatment if they take the diabetes medication metformin...
New research has found that a simplified regimen of clot-preventing medication following stent placement in adults with atrial fibrillation (AF) was just as safe...
Volta Medical has announced the US launch of the AF-Xplorer II system, the company's next-generation artificial intelligence (AI) solution designed to simplify real-time assessments...
Johnson & Johnson (J&J) MedTech has announced that new clinical and real-world data from its integrated-by-design Varipulse platform in pulsed field ablation (PFA) procedures for...
An artificial intelligence (AI) algorithm paired with the single-lead electrocardiogram (ECG) sensors on a smartwatch accurately diagnosed structural heart diseases, a study to be...
AtriCure has announced that the first patient was recently enrolled and treated in the BoxX-NoAF clinical trial, which is assessing the safety and effectiveness...
YorLabs, a medical technology company developing next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology (IC) procedures, has announced that the US Food...
Stereotaxis and CardioFocus have announced that they have entered into a collaboration agreement to advance robotic pulsed field ablation (PFA) technology towards commercialisation.
This collaboration is set...
A prospective study indicates that the prevalence of new-onset atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery may be significantly higher than...
Conformal Medical has announced the initiation of patient enrolment in the European Union (EU) for the CONFORM pivotal trial. The first EU procedure was...
Biotronik has today announced the successful first-in-human implantation of a device from its new Acticor/Rivacor Sky implantable cardioverter defibrillator (ICD)/cardiac resynchronisation therapy-defibrillator (CRT-D) portfolio...
Omron Healthcare has announced that cumulative worldwide sales of Omron blood pressure monitors (BPMs) have exceeded 400 million units.
This underscores the company’s longstanding commitment...
Stereotaxis has announced the successful first procedures by physicians at Erasmus University Medical Center in Rotterdam, The Netherlands, using the company’s Genesis robotic magnetic...
Boston Scientific has received CE-mark approval to expand the indication for its current-generation Ingevity+ pacing leads—thin wires that are implanted in the heart and...
Argá Medtech has announced initial enrolments in the COHERENT-AF pivotal clinical trial. This US Food and Drug Administration (FDA) investigational device exemption (IDE), prospective,...
Medtronic has announced the initiation of a pivotal study evaluating the use of elevated and personalised cardiac pacing rates for the treatment of patients...
AccurKardia has announced the initiation of a multicentre clinical pilot study of AK+ Guard—a US Food and Drug Administration (FDA) Breakthrough Device designated, artificial...
An individually tailored, multidimensional risk-based treatment strategy was not associated with improvements in clinical outcomes compared with usual guideline-based care in patients with atrial...
Biotronik has announced the market release of Solia CSP S—the latest innovation in its growing portfolio of conduction system pacing (CSP) solutions. Solia CSP S is the “first...
HeartBeam has announced new study data demonstrating no significant differences in the detection of atrial fibrillation (AF), atrial flutter and sinus rhythm when the...
At the 2025 European Society of Cardiology (ESC) congress (29 August–1 September, Madrid, Spain), Boston Scientific shared two late-breaking presentations pertaining to its Farapulse...
Procedure-related infection rates are similar between reconditioned and new pacemakers, potentially offering a "new hope" to patients in low- and middle-income countries (LMICs), according...
In recognition of National Atrial Fibrillation (AF) Awareness Month in the USA (September), StopAfib.org has launched the 2025 ‘Get in Rhythm. Stay in Rhythm.’...
Adding digital twin-guided ablation to a standard ablation technique can improve outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented...
Kardium has announced that it has received premarket approval (PMA) for the Globe pulsed field ablation (PFA) system, and 510(k) clearance for both the...
Pulsed field ablation (PFA) did not demonstrate superior efficacy to radiofrequency (RF) ablation in patients with drug-resistant, paroxysmal atrial fibrillation (AF) within the BEAT-PAROX-AF...
Laza Medical has announced the successful completion of its first software-only human cases at a US medical institution, marking the first time its real-time,...
Stereotaxis has announced the successful completion of the world’s first procedures using Magic Sweep—the “first and only” robotically navigated, high-density electrophysiology (EP) mapping catheter....
Researchers recently presented three new datasets reinforcing the safety and performance of Medtronic’s OmniaSecure defibrillation lead at the 2025 European Society of Cardiology (ESC)...
Prophylactic implantable cardioverter defibrillator (ICD) therapy does not appear to reduce mortality in patients with a prior myocardial infarction (MI), persistent moderate left ventricular...
Johnson & Johnson (J&J) MedTech has today announced acute safety and effectiveness results from the VARIPURE substudy of the SECURE study evaluating the company’s Varipulse...
A mail-based atrial fibrillation (AF) screening programme with electrocardiogram (ECG) patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure...
Discontinuing oral anticoagulation (OAC) therapy may result in a lower risk of a composite of stroke, systemic embolism or major bleeding versus continuing OAC...
Targeting high-normal potassium levels can reduce the risk of arrhythmias, hospitalisation for heart failure or arrhythmia, and death, compared with no intervention, according to...
Conformal Medical has announced the successful closing of its Series D extension financing, with a new partner joining inside investors to raise a total...
Orchestra BioMed has announced the publication of data in the Journal of the American College of Cardiology: Clinical Electrophysiology from a pressure-volume (PV) loop...
Pulsecare Medical has announced that its innovative NxPFA nanosecond pulsed field ablation (ns-PFA) system has received marketing approval from China's National Medical Products Administration (NMPA).
As the...
Omron Healthcare announced recently that it has successfully concluded a three-month study demonstrating how remotely monitored vital signs can facilitate early medical intervention in...
Royal Philips has announced a collaboration through which the company will integrate its suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty...
Orchestra BioMed has secured US$70 million in new capital from Ligand Pharmaceuticals and Medtronic to advance its late-stage partnered cardiology programmes—arterioventricular interval modulation (AVIM)...
Cardiosense has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the CardioTag device—claimed by the company to be...
Stereotaxis has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Magic Sweep catheter—described by the company as...
Biotronik has announced a strategic distribution agreement with CardioFocus to advance ablation treatment for cardiac arrhythmias, with Biotronik serving as the exclusive distributor of...
DeepQure has announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of the company’s HyperQure renal denervation (RDN) system—a...
Scar tissue in the heart—myocardial fibrosis—may be associated with abnormal heart rhythms among healthy, long-time male endurance athletes aged 50 years or older, potentially...
Researchers from the University of California San Francisco (UCSF) in San Francisco, USA recently set out to better understand the relationship between transseptal puncture...
AtriCure has announced the completion of enrolment in the LeAAPS clinical trial—a prospective, randomised, blinded, superiority investigational device exemption (IDE) trial evaluating the AtriClip...
Ceryx Medical has announced the successful close of a new funding round, bringing the company’s total raised to US$15 million.
The company’s lead product—a temporary...
Royal Philips has announced the launch of the Philips electrocardiogram (ECG) artificial intelligence (AI) marketplace—a platform that gives cardiac care teams access to multiple vendor...
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation (MR) are more...
Boston Scientific Corporation has received US Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labelling for the Farapulse pulsed...
Stereotaxis has announced the publication in the Journal of Interventional Cardiac Electrophysiology of initial clinical results from a first-in-human study utilising the MAGiC catheter—the...
Field Medical and Kardium—two companies developing pulsed field ablation (PFA) systems for the treatment of heart rhythm disorders—have secured funding rounds worth US$35 million...
Cathvision has announced the market release of ECGenius system version 3.4, introducing multiple software enhancements aimed at improving procedural workflow and physician usability across...
Johnson & Johnson (J&J) MedTech has announced the launch of the Varipulse platform—a system used to perform catheter ablation procedures for the treatment of...
The UK’s National Institute for Health and Care Excellence (NICE) has today published new guidance recommending the use of pulsed field ablation (PFA) in...
Merit Medical recently announced the appointment of Martha Aronson as the company's new president and chief executive officer (CEO), effective 3 October 2025. Fred...
The presence of atrial fibrillation (AF) may reduce the likelihood of mechanical thrombectomy being successful at the first attempt in patients with acute ischaemic...
New research presented at the 2025 European Academy of Neurology (EAN) congress (21–24 June, Helsinki, Finland) has uncovered a notable link between nighttime heart...
Vivasure Medical has announced the submission of a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for its PerQseal Elite...
Volta Medical has announced a “significant update” to the US labelling of its flagship system, Volta AF-Xplorer. Labelling will now include “groundbreaking” clinical data...
Ceryx Medical has announced the successful closure of a new funding round, bringing the company’s total raised to US$15 million, with the new investment...
New regulations have come into effect in the UK which place a greater emphasis on medical device manufacturers to monitor the safety and performance...
The international STEEER-AF study has shown that targeted online education on atrial fibrillation (AF) for health professionals can improve guideline-adherent care. This cluster-randomised controlled trial,...
Atraverse Medical has announced the close of US$29.4 million in follow-on financing to accelerate growth, building upon the US$12.5 million in prior seed investment...
Cardiac monitoring company PaceMate has announced the appointment of JR Finkelmeier as its new chief executive officer (CEO).
Finkelmeier joined PaceMate as chief commercial officer...
Medicare patients with atrial fibrillation (AF) who undergo surgical ablation during isolated coronary artery bypass grafting (CABG) live longer than those who do not,...
Johnson & Johnson (J&J) MedTech has announced the US launch of the Soundstar Crystal ultrasound catheter for intracardiac echocardiography (ICE) imaging in cardiac ablation procedures.
The...
Omron Healthcare has introduced home blood pressure monitors with built-in, artificial intelligence (AI)-powered detection of atrial fibrillation (AF). In what the company describes as...
Royal Philips has today announced the introduction of its VeriSight Pro 3D intracardiac echocardiography (ICE) catheter in Europe. Building on its success in the USA,...
An artificial intelligence (AI)-enabled, electrocardiogram (ECG)-based algorithm has performed well in the early detection of heart failure among healthcare-seeking individuals in Kenya, according to...
This advertorial is sponsored by Boston Scientific.
Given the ever-increasing wealth of clinical data and experiences involving pulsed field ablation (PFA) for the treatment of...
HeartBeam has announced that its “groundbreaking” synthesised 12-lead electrocardiogram (ECG) successfully met the clinical endpoints in the VALID-ECG pivotal study. Thomas Deering (Piedmont Heart...
The TRANSFORM-AF study has found that patients with atrial fibrillation (AF) and obesity who were treated with a glucagon-like peptide-1 receptor agonist (GLP-1 RA)...
Circa Scientific has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the PeriCross epicardial access kit (formerly Rook),...
Implicity has revealed new findings from its EVIDENCE-RM study, which—by leveraging extensive data from the French National Health Data System (SNDS)—has demonstrated clear clinical...
New research unveiled at the 2025 Heart Rhythm Society (HRS) annual meeting (24–27 April, San Diego, USA) has underscored the critical role of artificial...
Among a great number of presentations relating to pulsed field ablation (PFA) treatments for atrial fibrillation (AF) at this year’s Heart Rhythm Society (HRS)...
Kardium has announced late-breaking, one-year clinical trial results with its innovative pulsed field ablation (PFA) device—the Globe PF system.
Pivotal findings from the PULSAR...
The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a joint scientific statement on new guiding principles for same-day...
Field Medical has announced that its FieldForce ablation system was recently featured in a scientific presentation at the 2025 Heart Rhythm Society (HRS) annual...
Abbott has announced late-breaking data from the AVEIR conduction system pacing (CSP) acute clinical feasibility study, demonstrating the safety and performance of the company’s investigational...
Medtronic has received US Food and Drug Administration (FDA) approval of the OmniaSecure defibrillation lead for placement within the right ventricle. The lead—based on...
Atraverse Medical has announced that the latest clinical evidence on the efficacy and safety of its Hotwire left heart access system were presented at...
Boston Scientific has announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial evaluating the use of the...
Johnson & Johnson (J&J) MedTech has announced positive initial three-month results from the Omny-IRE study evaluating the investigational Omnypulse platform in patients with paroxysmal...
SoloPace Incorporated has announced both US Food and Drug Administration (FDA) clearance and first-in-human use of its SoloPace control system for temporary pacing in...
Stereotaxis announced recently that it hosted a demonstration of the GenesisX robotic system at this year’s Heart Rhythm Society (HRS) meeting (24–27 April, San...
EBR Systems has received US Food and Drug Administration (FDA) approval of the WiSE system—marking what the company describes as a significant leap forward...
The US Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an atrial fibrillation (AF) centre of excellence (CoE) and key...
Field Medical has announced the successful closing of US$40 million in Series A financing. The round includes US$20 million in new capital and the conversion of US$20 million in seed-round...
Orchestra BioMed Holdings has announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for atrioventricular interval modulation (AVIM) therapy.
The...
A left bundle branch pacing (LBBP) approach has been shown to be superior to biventricular pacing with regard to reducing long-term all-cause mortality and...
Luma Vision has announced the US Food and Drug Administration (FDA) clearance of its Verafeye visualisation platform.
As per a company press release, this...
Volta Medical—a company that develops artificial intelligence (AI) solutions to assist electrophysiologists—has announced the appointment of Bill Hoffman as executive chairman of its board of directors.
A...
AtriCure has announced the first use of the newest AtriClip device for minimally invasive concomitant procedures, the AtriClip PRO-Mini left atrial appendage (LAA) exclusion...
At this year’s European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria), a late-breaking presentation of data from the SINGLE SHOT...
The use of antidepressant (AD) medications has been linked to a substantial increase in the risk of sudden cardiac death (SCD), as per research...
A novel cardiac ablation system may hold the potential to improve upon the currently available treatments for ventricular arrhythmia (VA) patients, having demonstrated positive...
Pacemaker implantation within 30 days after a transcatheter aortic valve implantation (TAVI) procedure has been found to correlate with significantly higher rates of all-cause...
Medtronic recently announced that the first patient has been enrolled in a US Food and Drug Administration (FDA) early feasibility study evaluating the Affera...
A new study presented by researchers at the 2025 European Heart Rhythm Association (EHRA) congress (30 March–1 April, Vienna, Austria) demonstrates how, using artificial...
Conformal Medical has announced the enrolment of its 500th patient in the CONFORM investigational device exemption (IDE) trial, the prospective, multicentre, randomised controlled study...
The European Society of Cardiology (ESC) has released what it describes as a “groundbreaking” consensus statement on conduction system pacing (CSP), marking a “significant...
Johnson & Johnson (J&J) MedTech has today announced 12-month results from the SmartfIRE study, delivered as a late-breaking presentation at the ongoing European Heart...
New findings from the SINGLE SHOT CHAMPION trial, presented at the ongoing European Heart Rhythm Association (EHRA) congress (30 March–1 April 2025, Vienna, Austria)...
In a Cardiac Rhythm News guest article, chief investigators Nikolaos Dagres and Gerhard Hindricks (both Berlin, Germany) provide a window into the PROFID EHRA...
Abbott announced yesterday that it has received CE-mark approval in Europe for the Volt pulsed field ablation (PFA) system to treat patients with atrial...
This year’s congress of the European Heart Rhythm Association (EHRA; 30 March–1 April, Vienna, Austria), a branch of the European Society of Cardiology (ESC),...
AtaCor Medical has announced that it has initiated its ASCEND EV study—a prospective, non-randomised international study aiming to evaluate the safety and performance of...
GE HealthCare has announced the launch of the AltiX AI.i edition of its Mac-Lab, CardioLab and ComboLab cath lab and electrophysiology (EP) lab systems.
The...
A software robot has proved to be faster than doctors at detecting side-effects during a drug treatment for cardiac arrhythmia, while also cutting unnecessarily...
MedLumics has announced the publication of first-in-human results for the AblaView pulsed field ablation (PFA) system in atrial fibrillation (AF) patients, including clinical safety...
Stereotaxis has announced a US Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic...
Cadrenal Therapeutics has announced the signing of a collaboration agreement with Abbott to support Cadrenal’s pivotal TECH-LVAD trial.
Cadrenal Therapeutics is a late-stage biopharmaceutical company...
DeepQure has announced progress of clinical trials of its extravascular renal denervation device, HyperQure, and is expanding its technology to address atrial fibrillation (AF),...
With cases of cardiac arrhythmias rising rapidly, cardiologists from the European Heart Rhythm Association (EHRA) have marked Pulse Day (1 March) by urging communities...
Boston Scientific’s vice president (VP) of rhythm management, Caroline Bravo, speaks to Cardiac Rhythm News about the arrival of pulsed field ablation (PFA) for...
Research from Amsterdam UMC (Amsterdam, The Netherlands) and Johns Hopkins University (Baltimore, USA), published recently in the European Heart Journal, could represent an important step...
Following a temporary, voluntary pause of US external evaluation and all US cases with its Varipulse catheter, Johnson & Johnson (J&J) is set to...
Cathvision has announced the receipt of a CE mark for its breakthrough product, the ECGenius system. According to the company, this regulatory milestone allows...
New findings from the DiVERT Stroke clinical study show that women spent less time in the hospital, saw fewer referrals to cardiology and were...
Boston Scientific Corporation has announced it has received CE-mark approval for its navigation-enabled Farawave Nav ablation catheter in the treatment of paroxysmal atrial fibrillation...
Volta Medical has announced the publication in Nature Medicine of the TAILORED-AF clinical trial, which demonstrated that an artificial intelligence (AI)-guided procedure for persistent atrial...
First-in-human results of a novel transseptal puncture device from Protaryx Medical were presented at the 2025 Society of Thoracic Surgeons (STS) annual meeting (25–27...
Stereotaxis has announced that it recently received European CE-mark approval for the MAGiC ablation catheter. A press release highlights this approval is a “significant...
Lucia and the Heart Rhythm Society (HRS) have announced a strategic collaboration to leverage Lucia's cutting-edge technology to enhance UpBeat.org—the HRS’ premier online resource...
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
Researchers from Mass General Brigham (Boston, USA) have evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients...
Pulse Biosciences has announced late-breaking data from the first-in-human feasibility study of its nanosecond pulsed field ablation (nsPFA) 360-degree cardiac catheter system at the...
Taho Pharmaceuticals has announced the completion of the pivotal trial for TAH3311, an anticoagulant oral dissolving film (ODF).
The trial was conducted following detailed discussions...
AliveCor has announced that the US Centers for Medicare & Medicaid Services (CMS) has included the company's artificial intelligence (AI)-powered electrocardiogram (ECG) technology in...
Clinical evidence supporting the efficacy, safety and efficiency of Atraverse Medical's Hotwire left-heart access system was presented recently at the 30th annual AF symposium...
Boston Scientific announced data supporting the use of the Farapulse pulsed field ablation (PFA) system and the Watchman FLX left atrial appendage closure (LAAC) device,...
Luma Vision has announced the successful first-in-human device use and enrolment in its LUMINIZE clinical study involving the “groundbreaking” Verafeye platform. A company press release...
Primary results from the DEFINE AFib clinical study have found that Medtronic's LINQ family of insertable cardiac monitors (ICMs), paired with a novel algorithm,...
AliveCor has announced new data published in the journal Computing in Cardiology (CINC) demonstrating that its Kardia 12L electrocardiogram (ECG) system—the “world's first” artificial intelligence (AI)-powered,...
Circa Scientific has announced the launch of its innovative Crosswise radiofrequency (RF) transseptal access system, which is designed to provide precise puncture of the septal...
Biotronik has announced the first in-human implantations in the BIO-Master.CSP study examining the use of the company’s investigational, next-generation Solia conduction system pacing (CSP)...
Peerbridge Health has announced the launch of its COR-INSIGHT trial, which will validate the screening and diagnostic capabilities of its Peerbridge Cor ambulatory electrocardiography...
Johnson & Johnson MedTech has announced European CE mark approval of the Dual Energy Thermocool Smarttouch SF catheter for the treatment of cardiac arrhythmias.
The...
The US Food and Drug Administration (FDA) has issued draft guidance that includes recommendations to support development and marketing of safe and effective artificial...
Abbott has announced the successful completion of the “world's first” in-human leadless left bundle branch area pacing (LBBAP) procedures using the company's investigational Aveir...
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment. A...
The US Food and Drug Administration (FDA) has alerted patients, caregivers and healthcare providers about the potential need for early device replacement of Boston...
Field Medical has announced that its FieldForce ablation system has been accepted into the US Food and Drug Administration (FDA)’s Total Product Life Cycle Advisory...
Protaryx Medical has announced the completion of its first-in-human (FIH) study, assessing its advanced transseptal puncture technology.
Conducted on 3 December 2024 at Sanatorio Italiano...
CathVision has unveiled the latest ECGenius system update—a release that brings essential enhancements to streamline workflows and boost procedural efficiency in electrophysiology (EP) labs,...
BTL Medical has announced the successful treatment of the first six patients in a first-in-human feasibility study using its next-generation catheter system designed to...
Manipal Hospitals—one of the largest healthcare networks in India—has announced the successful insertion of an artificial intelligence (AI)-driven wireless injectable pacemaker.
The Aveir leadless...
New research suggests that cryoablation is a safe and effective approach to closing congenital patent foramen ovale (PFO) in patients with atrial fibrillation (AF)...
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center (Austin, USA) recently became the first in the USA to use...
Late-breaking results from the PROMPT-AF, CRRF-PeAF and ARREST-AF trials were presented recently at the American Heart Association (AHA) Scientific Sessions (16–18 November 2024, Chicago, USA),...
New research published in the European Heart Journal has shown that, among patients who have had a heart attack, it is “extremely difficult” to accurately predict...
Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both, did not improve atrial fibrillation (AF) burden or progression...
In patients with atrial fibrillation (AF) or atrial flutter, COVID-19 vaccination appears to be “generally not associated with an increased risk of thromboembolic events”,...
Latest data from the Amulet investigational device exemption (IDE) trial, comparing the Amplatzer Amulet (Abbott) left atrial appendage occluder (LAAO) to the first-generation Watchman...
Ceryx Medical has announced that the first patient has been enrolled in the RSA-Pace multicentre study at Waikato Hospital in Hamilton, New Zealand evaluating...
Prescribing anticoagulation medications to adults younger than 65 years of age who have atrial fibrillation (AF) but no other risk factors for stroke does not...
Three-year results from the OPTION clinical trial, comparing the Watchman FLX (Boston Scientific) left atrial appendage closure (LAAC) system to oral anticoagulation for stroke...
Ablation may be a better first-line treatment for heart attack survivors experiencing dangerous episodes of ventricular tachycardia (VT), according to late-breaking science presented recently...
A randomised trial comparing previously used and new pacemakers in patients with heart rhythm disorders has found reconditioned devices to be as safe and...
Two innovative electrocardiogram (ECG) products have gained new US Food and Drug Administration (FDA) clearances for monitoring cardiac arrhythmias—Fourth Frontier’s Frontier X Plus (FX+)...
In a paper published recently in the journal Chaos, researchers from Sergio Arboleda University (Bogotá, Colombia) and the Georgia Institute of Technology (Atlanta, USA) used...
An extra hour of physical activity every week may lower a person’s chance of developing the most common type of arrythmia by 11%, a...
Stereotaxis has announced that physicians at the University of Kansas Health System (Kansas City, USA)—a system renowned for diagnosing and treating complex heart conditions—have...
A recent study published in JACC: Clinical Electrophysiology has placed emphasis on the importance of building research capacity for ambulatory rhythm monitoring in sub-Saharan...
Pulse Biosciences has announced the appointment of David Kenigsberg (Florida Heart Rhythm Specialists, Fort Lauderdale, USA) as chief medical officer (CMO) of Electrophysiology. In...
Johnson & Johnson (J&J) MedTech has announced the US Food and Drug Administration (FDA) approval of the Varipulse pulsed field ablation (PFA) platform for...
People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than...
MedLumics recently announced that 10 patients have been treated in the company’s first-in-man clinical trial, which is ongoing and currently under protocol-dictated follow-up. The...
Boston Scientific Corporation announced today that it has entered into a definitive agreement to acquire Cortex, an Ajax Health company and privately held medical...
Adagio Medical has announced the completion of the first procedures in the FULCRUM-VT US Food and Drug Administration (FDA) pivotal investigational device exemption (IDE)...
Abbott has announced a new, “first-of-its-kind” clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy...
Medtronic has announced US Food and Drug Administration (FDA) approval of the Affera mapping and ablation system with Sphere-9 catheter, an all-in-one, high-density (HD)...
Boston Scientific has announced that the National Institute for Health and Care Excellence (NICE), has issued guidance recommending the use of the HeartLogic heart...
The Heart Rhythm Society (HRS) board of trustees has unanimously approved the formation of Heart Rhythm Advocates—a new, shared-vision, cause-related non-profit 501(c)(4) advocacy organisation...
Boston Scientific Corporation has announced that it has received US Food and Drug Administration (FDA) approval of the navigation-enabled Farawave Nav ablation catheter for...
Abbott announced today that it has achieved new, major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology.
These...
Adjunctive coronary sinus isolation (CSI) as part of a de-novo ablation strategy does not confer any additional benefit compared to pulmonary vein isolation (PVI)...
A patient’s pattern of atrial fibrillation (AF) at their initial diagnosis does not influence their rate of AF recurrence, nor their AF burden, following...
Conformal Medical has announced the initiation of the GLACE Study, assessing the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA)...
The Health Policy and Regulatory Affairs Committee of the Heart Rhythm Society (HRS) has published a statement online in the Heart Rhythm Journal reaffirming the important role...
Boston Scientific has announced receipt of Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the Farapulse pulsed field ablation (PFA) system. The...
Medtronic has announced the presentation of clinical study results demonstrating a high rate of durable lesion formation with the PulseSelect pulsed field ablation (PFA)...
Boston Scientific recently announced late-breaking data from the MODULAR ATP clinical trial investigating the pacing performance of the company’s Empower leadless pacemaker. The data...
Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now...
Merit Medical Systems has announced that it recently signed a definitive asset purchase agreement to purchase Cook Medical’s lead management portfolio for a total...
The treatment of atrial fibrillation (AF) via a novel, ‘single-shot’ spherical array approach to pulsed field ablation (PFA) has been found to achieve durable...
Medtronic recently shared long-term results from the global EV ICD pivotal trial, reinforcing the performance and safety of the company’s extravascular implantable cardioverter defibrillator...
Quitting cigarettes can significantly lower a person’s risk of atrial fibrillation (AF) compared to those who continue to smoke, according to a study published...
Boston Scientific has announced the appointment of Angelo Auricchio as chief medical officer (CMO) of the company’s Rhythm Management business in Europe, the Middle...
Mass screening for atrial fibrillation (AF) using electrocardiography (ECG) together with a heart failure biomarker does not prevent ischaemic stroke or systemic in older...
Abbott has announced that, as of 6 September, it will be rolling out its Aveir dual-chamber (DR) leadless pacemaker system across the UK. In...
In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in...
Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe—but, a structured educational programme for healthcare professionals...
B-Secur has announced the US Food and Drug Administration (FDA) clearance and launch of HeartKey Rhythm—a suite of electrocardiogram (ECG) algorithms and analytics designed...
Screening for atrial fibrillation (AF) using a wearable heart monitor for two weeks can identify older adults with this potentially dangerous abnormal heart rhythm,...
As per late-breaking research presented recently at the 2024 European Society of Cardiology (ESC) congress (30 August–2 September, London, UK), cryoballoon (CB) ablation is...
A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF), and results...
Research presented at the 2024 European Society of Cardiology (ESC) congress (30 August–2 September, London, UK) will show that performing echocardiograms remotely using a...
AtriCure has announced that the first patient has been treated with the AtriClip FLEX-Mini left atrial appendage (LAA) exclusion device, which recently received US...
Biosense Webster has announced the enrolment completion of the Omny-IRE clinical trial.
Omny-IRE is a prospective, multicentre, non-randomised clinical trial that enrolled 188 patients in...
AtriCure has received an expanded indication for the AtriClip left atrial appendage (LAA) exclusion system in CE-marked countries in Europe.
The product is now indicated...
Work-related stress caused by job strain and an “imbalance between efforts applied versus rewards received” may increase the risk of developing atrial fibrillation (AF),...
A study utilising nationwide healthcare data from across Denmark has indicated that, during catheter ablation procedures, conscious sedation (CS) may be linked to a...
The US Patient-Centered Outcomes Research Institute (PCORI) has announced the approval of funding awards totalling more than US$165 million for new patient-centred, comparative clinical...
Pulse Biosciences has announced treatment of the first two patients in a first-in-human feasibility study using its novel nanosecond pulsed field ablation (nsPFA) cardiac...
BioCardia has submitted a 510(k) for approval of its patented Morph DNA steerable introducer sheath to the US Food and Drug Administration (FDA).
This product...
Adagio Medical has announced the completion of its business combination with ARYA Sciences Acquisition Corp IV—a special purpose acquisition company sponsored by an affiliate...
Element Science has announced the publication of results from its Jewel investigational device exemption (IDE) study—conducted at sites across the USA—in the Journal of...
The Hotwire radiofrequency (RF) guidewire device from Atraverse Medical has been used for the first time in clinical practice by world-renowned cardiac electrophysiologist Devi Nair...
Ceryx Medical has announced the approval of a trial evaluating Cysoni-XT—a new temporary cardiac pacemaker aiming to boost recovery in heart failure.
The UK Medicines...
FibriCheck—a smartphone or smartwatch app capable of measuring a patient’s heart rhythm and detecting possible arrhythmias—has been cleared by the US Food and Drug...
AtriCure has received regulatory approval from the National Medical Products Administration (NMPA) of China to market and sell several models of its AtriClip left...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot respiratory sinus arrhythmia (RSA)-pace...
Royal Brompton Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust (London, UK) has become the first hospital in the UK to install...
Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments...
A patient in Cincinnati has become the first in the USA to receive a system that enables remote monitoring of his heart and congestion...
This advertorial is sponsored by Boston Scientific
The arrival of pulsed-field ablation (PFA) has been heralded by many experts in the field of arrhythmia management...
This advertorial is sponsored by Biosense Webster
Biosense Webster founded the AFib Symposium in 2002. Now in its 22nd year, the annual event combines practical...
Entries have opened for the second edition of the Global Cardiovascular Awards, celebrating innovation and excellence in the field of cardiovascular healthcare.
Returning on 13...
Adona Medical has secured US$33.5 million in Series C financing, with the money to be used to further product development and initiate clinical use...
Cordis recently announced that the US Food and Drug Administration (FDA) has granted premarket approval for its Mynx Control venous vascular closure device (VCD)...
Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), findings of the largest real-world registry of the...
Investment in a programme of clinical trials will underpin Boston Scientific’s strategy to expand the uptake of its Watchman left atrial appendage closure (LAAC)...
Kardium, developer of the Globe mapping and ablation system for the treatment of atrial fibrillation (AF), has raised US$104 million in a new financing...
Abbott has received CE mark in Europe for the Aveir dual chamber (DR) leadless pacemaker system.
The Aveir DR leadless pacemaker system utilises a new...
Results of the SPHERE Per-AF study, investigating the safety and efficacy of Medtronic’s Sphere-9 catheter, have been presented at the Heart Rhythm Society (HRS)...
Medtronic has announced that its investigational OmniaSecure defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals in the global LEADR...
Insights from the FARADISE registry, studying real-world outcomes from more than 1,000 patients to have undergone catheter ablation for paroxysmal and non-paroxysmal atrial fibrillation...
Patients with previous paroxysmal atrial fibrillation (AF) who follow a Mediterranean diet enriched with extra-virgin olive oil after a catheter ablation procedure saw improved...
Six-month results from the ongoing pivotal MODULAR ATP clinical trial assessing the Boston Scientific’s mCRM modular cardiac rhythm management (CRM) system were presented at...
Late-breaking results from the pivotal phase of the admIRE pivotal clinical trial, alongside results from the VIRTUE study—both assessing the Varipulse (Biosense Webster) pulsed...
Atraverse Medical has announced US Food and FDA clearance of its Hotwire radiofrequency (RF) guidewire, a novel device that enables zero exchange left-heart access...
Adagio Medical has announced the completion of the first commercial procedures using its recently CE marked ventricular tachycardia (VT) cryoablation system and the US...
Biosense Webster has announced the launch of the latest version of the its three-dimensional (3D) heart mapping system used in cardiac ablation procedures—Carto 3...
Corvia Medical has announced the publication of two-year echocardiographic data from its REDUCE LAP-HF II randomised clinical trial of the Corvia atrial shunt in...
Thermedical, a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilising pulsed field ablation...
Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the EVERCOOL AF study,...
Patients with heart failure who had an interatrial shunt inserted between the left and right atria did not see any significant benefits overall compared...
Biotronik has announced the CE mark approval and first European implant of its latest insertable cardiac monitor (ICM)—Biomonitor IV.
The device features artificial intelligence (AI)...
Three-month follow-up results from the SmartfIRE clinical trial, investigating Biosense Webster’s Thermocool Smarttouch SF dual energy catheter were presented in a late-breaking trial session...
Clinical findings of the B3 study, assessing the impact of closed loop stimulation on the incidence of sub-clinical atrial fibrillation (AF) in sinus node...
Interim first-in-human clinical safety and efficacy results for Medtronic’s Sphere-360 investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of...
A randomised trial investigating preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of...
A trial of technology using ultra-low temperature cryoablation (ULTC) has shown that the technique eliminated clinical ventricular tachycardia (VT) in 94% of patients.
The finding...
An international consensus statement on how to treat atrial fibrillation (AF) with catheter or surgical ablation has been published today in EP Europace and...
Boston Scientific has initiated the NAVIGATE-PF study of the Faraview software module when it is used to visualise and track the Farawave Nav pulsed...
Automated external defibrillators (AEDs) were used in in 13 of nearly 1,800 cases of out-of-hospital cardiac arrest, even though many of the incidents occurred...
GE HealthCare has announced the launch of Caption AI artificial intelligence (AI)-driven software for Vscan Air SL, its dual-headed, handheld, wireless, point-of-care ultrasound imaging...
Kardium has announced the successful completion of enrolment in the paroxysmal cohort of the pivotal PULSAR IDE (investigational device exemption) study of the Globe...
Viz.ai has announced a strategic collaboration with Medtronic to improve the coordination of cryptogenic stroke patient care between neurology and cardiology teams.
For stroke patients...
High-power short-duration ablation results in significantly shorter procedure times without affecting procedural efficacy and safety among patients undergoing ablation for atrial fibrillation (AF).
This is...
Biosense Webster has submitted a premarket approval application (PMA) to the US Food & Drug Administration (FDA) for its Varipulse platform. The submission was...
Adagio Medical has announced CE mark approval of its ultra-low temperature cryoablation (ULTC) system for the treatment of monomorphic ventricular tachycardia.
The system consists of...
Abbott has announced it has received CE mark in Europe for its Assert-IQ insertable cardiac monitor (ICM).
Physicians can insert the Assert-IQ ICM under the...
Following the recent CE approval of the Solia S lead for left bundle branch area pacing (LBBAP), Biotronik has announced the first complete conduction...
People at risk should be tested for atrial fibrillation (AF) every time they attend a health appointment, according to results of the AFFECT-EU project....
HeartBeam has announced that it has enrolled the first patients in the VALID-ECG pivotal study. The first patients were enrolled at Atlanta Heart Specialists...
The US Food and Drug Administration (FDA) has approved an additional indication for the weight loss drug semaglutide—marketed as Wegovy (Novo Nordisk) —to reduce...
Stereotaxis has announced that regulatory submissions were made recently in both Europe and the USA for the MAGiC catheter. These submissions follow initial clinical...
Haemonetics Corporation has entered into a definitive agreement to acquire Attune Medical, the manufacturer of the ensoETM proactive oesophageal cooling device, the only US...
Six-month results from the PROACTIVE-HF pivotal trial, evaluating the Cordella pulmonary artery (PA) sensor (Endotronix) in New York Heart Association (NYHA) class III heart...
BioCardia has announced interim results from the phase III randomised controlled trial of its CardiAMP autologous cell therapy in 110 randomised patients with advanced...
Volta Medical has announced CE mark for its Volta AF-Xplorer, an artificial intelligence (AI) companion that is cleared in the USA for the real-time...
Biosense Webster has announced the receipt of European CE mark approval for the Varipulse platform for the treatment of symptomatic drug refractory recurrent paroxysmal...
FIRE1 today announced that it has completed patient enrolment in the US early feasibility study—FUTURE-HF2—of its FIRE1 system for remote heart failure monitoring.
The FIRE1...
A scientific statement published by the American Heart Association (AHA) in Circulation today acknowledges the potential “transformative” impact of the technology on cardiovascular...
Researchers have detailed how artificial intelligence (AI) can be used to predict sudden cardiac arrest by studying patterns in electrocardiograms (ECGs) as well as...
VahatiCor has announced the treatment of the first patient with the A-Flux Reducer system, an interventional treatment for patients with angina or chest pain.
The...
Biosense Webster has announced the commencement of patient cases with the investigational Laminar left atrial appendage elimination (LAAX) system as part of its pivotal...
FineHeart has announced the successful filing of six new international patents for FlowMaker, a fully implantable device for the treatment of patients with advanced...
BiVACOR, a clinical-stage medical device company, has announced that US$13 million has been awarded from the Australian government’s Medical Research Future Fund (MRFF) grant...
Reprieve Cardiovascular, a development stage company focused on pioneering an automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, announced...
X-trodes has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Smart Skin solution, marketed as X-trodes...
A person’s chance of surviving while receiving cardiopulmonary resuscitation (CPR) for cardiac arrest in hospital declines rapidly from 22% after one minute to less...
Pulse Biosciences has announced favourable findings from the 60-day post-procedure evaluations for four initial patients treated in the Company’s CellFX nanosecond pulsed field ablation...
This advertorial is sponsored by Biosense Webster
The field of catheter ablation for atrial fibrillation (AF) is evolving. The development of pulsed field ablation (PFA),...
Biotronik has announced that it will solely supply the proprietary DX models for new single-chamber implantable cardioverter-defibrillators (ICDs) implants moving forward.
The move is being...
Biosense Webster has announced support for two collaborative studies, VIRTUE and POLARIS aiming to better understand the use and workflows with the investigational Varipulse...
Medtronic has announced new cost-effectiveness data from the STROKE AF clinical study, which showed that continuous monitoring with the Reveal LINQ insertable cardiac monitor...
Twelve-month results from the inspIRE study, investigating predictors of success for pulmonary vein isolation with pulsed field ablation (PFA) using a variable loop catheter...
Posterior wall ablation, a commonly used adjunct to pulmonary vein isolation (PVI), does not add any benefits for patients undergoing catheter ablation for persistent...
Findings of an investigation into whether ablation of non-pulmonary vein atrial fibrillation (AF) drivers identified by machine learning in addition to pulmonary vein isolation...
Data from the first US comprehensive single-centre experience at St Bernard’s Medical Center and Arrhythmia Research Group (Jonesboro, USA), presented at a late-breaking session...
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Farapulse pulsed field ablation (PFA) system.
The Farapulse PFA system is indicated...
Biotronik has announced the milestone achievement of 100,000 implanted single-chamber implantable cardioverter-defibrillators (ICDs) equipped with DX Technology.
Since the introduction of the technology in 2009,...
Element Science has announced that it has received CE mark certification and UK Conformity Assessed (UKCA) marking for its novel patch-wearable cardioverter defibrillator (P-WCD)...
The full shortlist for the inaugural Global Cardiovascular Awards—which will recognise the tireless work of individuals, teams and organisations to improve the life of...
Tributes have poured in from across the world of cardiology following the death of Bruce Wilkoff, a pioneer of cardiac electrophysiology and former president...
Abbott has announced the first global procedures have been conducted using the company’s new Volt pulsed field ablation (PFA) system to treat patients with...
Cardiac Dimensions, a developer of invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), has announced that interventional...
Occlutech has announced that the US Food and Drug Administration (FDA) has approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment...
Orchestra BioMed Holdings has announced the first patient was randomised in the BACKBEAT pivotal study in late December 2023.
The BACKBEAT pivotal study will evaluate...
CardioFocus has announced the acquisition of Galvanize Therapeutics' Electrophysiology Technology division.
Notable assets included in the acquisition are the Centauri system pulsed electric field generator,...
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal.
Recreational use...
Biosense Webster has today announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the Varipulse platform for the treatment of...
GE HealthCare has entered into an agreement to acquire MIM Software, a provider of artificial intelligence (AI)-enabled image analysis and workflow tools across multiple...
Stereotaxis has announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC.
Stereotaxis’ MAGiC catheter is a robotically navigated...
Medtronic has received CE mark for its Micra AV2 and Micra VR2, the next generation of its miniature, leadless pacemakers.
Micra AV2 and Micra VR2,...
Endotronix has submitted a premarket approval (PMA) application for its Cordella pulmonary artery (PA) sensor system to the US Food and Drug Administration (FDA).
Cordella...
iRhythm Technologies has announced that its long-term ambulatory cardiac monitor, the Zio monitor ECG system, has received CE mark certification under the European Union’s...
Pulse Biosciences has filed a premarket notification 510(k) to the US Food and Drug Administration (FDA) for its novel CellFX nanosecond pulsed field ablation...
Allowing patients to eat before elective cardiac catheterisation posed no safety risk and benefited patient satisfaction and overall care, research published in the American...
Boston Scientific has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the Farapulse pulsed field ablation (PFA) system as...
CardioRenal and CHU Grenoble Alpes have announced an innovation that allows chronically ill patients to measure their blood potassium levels autonomously and accurately.
The Tenor...
LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and navigation platform, has announced a total of US$22 million in new financing for...
Biosense Webster has announced the first patient cases with the investigational dual energy Thermocool Smarttouch SF catheter took place as part of the SmartPulse...
Which stories captured the attention of the electrophysiology community across 2023? Read our summary of the trending stories from across the Cardiac Rhythm News...
Results of the National Cardiogenic Shock Initiative—a single-arm multicentre study assessing the feasibility and effictiveness of utilising early mechanical circulatory support using the Impella...
Individuals infected with COVID-19 are also at an increased risk of suffering from cardiac arrhythmias, research published online in European Heart Journal Open has...
Smartwatches can help physicians detect and diagnose irregular heart rhythms in children, research published online in Communications Medicine has shown.
The finding comes from a...
Medtronic has announced that the US Food and Drug Administration (FDA) has approved the PulseSelect pulsed field ablation (PFA) system for the treatment of...
CathVision has announced the launch of ECGenius 3.1, an advanced version of its ECGenius system software.
The new version improves workflow and streamlines processes to...
Cardiovascular diseases, including ischaemic heart disease, stroke, heart failure, peripheral and aortic diseases, arrhythmias and valvular heart disease remain the leading global cause of...
The cardiologist and researcher, Harlan M Krumholz (Yale School of Medicine, New Haven, USA), has been named editor-in-chief of the Journal of the American...
Medtronic has announced the launch of its Penditure left atrial appendage (LAA) exclusion system in the USA.
The Penditure LAA Exclusion System is an implantable...
Procyrion has announced the enrolment of the first patients in the company’s investigational device exemption (IDE) pivotal trial.
The DRAIN-HF study will evaluate the Aortix...
The American College of Cardiology (ACC) and the American Heart Association (AHA), with several other medical associations, have issued new guidelines for the prevention...
Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, a medical device company focused on eliminating the left atrial appendage...
Healthcare 21 (HC21) has gained national reimbursement for Catheter Precision’s VIVO 3D mapping system in the UK following it being granted inclusion in National...
Abiomed has announced that the first patient in the world has been enrolled in the landmark RECOVER IV randomised controlled trial (RCT).
The on-label, two-arm...
Ischaemic strokes in atrial fibrillation (AF) patients are less often disabling or fatal if they have been treated with left atrial appendage closure procedure...
The occurrence of atrial fibrillation (AF) after mitral valve surgery may be more harmful than previously thought, the authors of a research paper in...
A clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction (MI) survivors with heart failure has enrolled its first patient....
Pulse Biosciences has announced the filing of a premarket notification 510(k) to the US Food and Drug Administration (FDA) for its novel CellFX nanosecond...
Medtronic has received CE mark for the PulseSelect pulsed field ablation (PFA) system and the Nitron CryoConsole.
The PulseSelect system is designed to treat atrial...
Element Science has announced the successful completion and presentation of the results of the Jewel investigational device exemption (IDE) study, assessing the Jewel patch-wearable...
Abbott has announced new late-breaking data that show advanced heart failure patients living with its HeartMate 3 left ventricular assist device (LVAD) who did...
Analysis of outcomes of more than 17,000 patients receiving pulsed field ablation (PFA) using the Farapulse (Boston Scientific) device reinforce the safety profile of...
RCE Technologies, the developer of a non-invasive, instant measurement of cardiac proteins was selected as the winner of the annual Health Tech competition at...
Use of apixaban in patients with sub-clinical atrial fibrillation (AF) resulted in a lower risk of stroke or systemic embolism than aspirin, but a...
Results of the SELECT clinical trial, presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA), have shown that overweight or...
Conformal Medical has announced positive one-year results from the company's CONFORMAL Early Feasibility Study (EFS).
William Gray (Lankenau Heart Institute, Wynnewood, USA) presented the Conformal...
Patients with atrial fibrillation (AF) undergoing a transcatheter aortic valve implantation (TAVI) at the same time as a left atrial appendage occlusion (LAAO) procedure...
Implicity has announced the results of a clinical study published in the Cardiovascular Digital Health Journal, reaffirming that its proprietary algorithm is highly effective...
Women with atrial fibrillation (AF) undergoing pulsed field ablation (PFA) have just as good outcomes as men according to a large-scale international study published...
Biosense Webster has announced new findings from the Q-FFICIENCY study have been published in the Journal of Cardiovascular Electrophysiology, which the company says demonstrate...
Medtronic has received US Food and Drug Administration (FDA) approval for the Aurora EV-ICD MRI SureScan (extravascular implantable cardioverter-defibrillator) and Epsila EV MRI SureScan defibrillation...
A research article in the journal Science has found that fibroblasts—scar-forming cells that reside in the scar tissue of an injured heart—directly play a...
FEops has entered into a partnership with ConcertAI’s TeraRecon for the commercialisation of FEops HEARTguide’s for left atrial appendage (LAA) occlusion workflow, with a...
Endotronix has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for a subsequent multicentre study, PROACTIVE-HF 2, which...
This advertorial is sponsored by Boston Scientific
Physicians at Na Homolce Hospital (Prague, Czech Republic) have recently completed their 2,000th clinical case using the FARAPULSE...
Pulse Biosciences has announced a collaboration with CardioNXT, to support the company’s planned nanosecond pulsed field ablation (nsPFA) cardiac catheter first-in-human study focused on...
Boston Scientific today launched the LUX-Dx II+ insertable cardiac monitor (ICM) system, describing it as a next-generation insertable monitor for long-term monitoring of arrhythmias...
Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a breakthrough artificial intelligence (AI)-powered medical device to detect low...
This advertorial has been sponsored by GE HealthCare.
In this white paper Usman Siddiqui (Advent Health, Orlando, USA) discusses the reasons why the Prucka 3...
Research published in JACC: Clinical Electrophysiology has found a significant reduction in the rate of atrioesophageal fistuals (AEFs) during cardiac ablation of the left...
Medtronic has announced the results from two analyses demonstrating survival benefits and a reduction in life-threatening cardiac events with the use of implantable cardioverter...
Abbott has announced that the company's TactiFlex ablation catheter has been used for the first time in Canada at the Foothills Medical Centre in...
Field Medical has closed its oversubscribed seed round with investments totalling US$14million.
The convertible note funding was led by private investors who were joined by...
Anthos Therapeutics has announced that the AZALEA-TIMI 71 Phase 2 study has been stopped early due to an “overwhelming” reduction in the composite of...
Biosense Webster has announced that the first cases have been performed using the investigational Omnypulse catheter as part of the Omny-IRE clinical trial. The...
Younger atrial fibrillation (AF) patients are most likely to benefit from more personalised, magntetic resonance imaging (MRI)-guided ablation, according to a new analysis of...
Switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral anticoagulant (NOAC) in frail elderly patients with atrial fibrillation (AF) is associated...
SmartCardia has received US Food and Drug Administration (FDA) clearance for its seven-lead real-time electrocardiogram (ECG) monitoring patch and cloud platform.
SmartCardia's 7L patch is...
Adagio Medical has announced the first ultra-low temperature cryoablation (ULTC) procedure performed using the Adagio vCLAS catheter system in the USA as part of...
Attune Medical has been granted de novo marketing authorisation from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the...
Stereotaxis has announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis robotic magnetic navigation...
Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap.
Designed to improve ablation outcomes and procedural...
Boston Scientific has received US Food and Drug Administration (FDA) approval for the latest-generation Watchman FLX Pro left atrial appendage closure (LAAC) device.
The device,...
Atrial fibrillation (AF) ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical...
Biotronik has announced the first US implantation of the Amvia Edge pacemaker. The procedure was successfully completed by Raul Weiss at Mount Sinai Medical...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new approved bodies to increase the country’s capacity to certify medical devices.
TÜV...
Results of the first randomised trial comparing pulsed field ablation (PFA) to thermal ablation for the treatment of paroxysmal atrial fibrillation (AF)—ADVENT—have shown that...
GE Healthcare has announced the launch of two new tools for the cardiology market, coinciding with the European Society of Cardiology (ESC) congress (25–28...
Oral anticoagulation in patients with atrial high rate episodes (AHRE) increases bleeding without reducing a composite outcome of stroke, systemic embolism or cardiovascular death.
This...
Physical fitness is linked with a lower likelihood of developing atrial fibrillation (AF) and stroke, a study of more than 15,000 people, to be...
The British Heart Foundation (BHF) has appointed research leader and NHS consultant physician Bryan Williams as its first chief scientific and medical officer.
Williams will...
AstraZeneca’s Forxiga (dapagliflozin) has been approved in China for use in adults with symptomatic chronic heart failure.
The drug has previously been approved in China...
Heart failure start-up Acorai has announced the initiation of a global clinical trial with the enrolment of its first patient in London, UK.
The Acorai...
An artificial intelligence (AI) model may be more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods.
This is...
Research published in the journal Circulation: Cardiovascular Quality and Outcomes has highlighted the small number of clinical trials in cardiovascular medicine currently conducted in...
CathVision has announced US Food and Drug Administration (FDA) clearance and commercial availability of the PVI Analyzer and Signal Complexity algorithms, part of the...
Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM)...
Ian Meredith is a well-known figure within the field of interventional cardiology, not only for a distinguished academic and clinical career but also his...
Boston Scientific has received US Food and Drug Administration (FDA) approval for the POLARx cryoablation system.
The new system, which is indicated for the treatment...
Patient-tailored catheter ablation results in a significant reduction in atrial tachyarrhythmia (ATA) burden in shock-resistant persistent atrial fibrillation (AF) patients using implantable cardiac monitors...
Ilika and Cirtec Medical have announced that they have signed a 10-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec’s...
Biosense Webster has announced that several products in its cardiac ablation portfolio have received approval for a zero fluoroscopy workflow from the US Food...
Researchers have presented a new method for assessing atrial remodelling in patients with atrial fibrillation (AF), based on the simultaneous assessment of electrical and...
The World Health Organization (WHO) has included a cardiovascular polypill—an all-in-one pill containing an antiplatelet, lipid lowering medication, and a blood pressure lowering and...
Applying artificial intelligence (AI) to a single apical four chamber (A4C) view echocardiogram provides accurate information to detect heart failure with preserved ejection fraction...
The combination of soaring heat and fine particulate pollution may double the risk of myocardial infarction (MI) mortality, according to a new study of...
This advertorial has been sponsored by GE Healthcare.
In this white paper Usman Siddiqui (University of Central Florida, Hunters Creek, USA) highlights reasons why the...
This post is sponsored by GE Healthcare
In this white paper, Usman Siddiqui (University of Central Florida, Hunters Creek, USA) highlight reasons why the Prucka...
Biosense Webster has today announced the US launch of the Optrell mapping catheter with Trueref technology powered by the Carto 3 system.
The Optrell mapping...
Entries are now open for the inaugural edition of the Global Cardiovascular Awards, a recognition scheme highlighting the important contributions made by healthcare professionals...
Biosense Webster has announced that enrolment has been completed in the SmartfIRE study evaluating the safety and efficacy of its investigational Thermocool Smarttouch SF...
The use of embedded electrocardiogram (ECG) sensors in shopping trolley handles could effectively identify individuals with previously undiagnosed atrial fibrillation (AF). This is among...
The Heart Rhythm Society (HRS) has announced the appointment of Sami Viskin (Tel Aviv University, Tel Aviv, Israel) as the new editor-in-chief of Heart...
Medtronic is recalling all implantable cardioverter defibrillator (ICD) and cardiac resynchronisation (CRT-D) devices manufactured after 2017 with a glassed feedthrough, as there is a...
Stereotaxis has announced that the first patients have been successfully treated utilising Abbott’s EnSite X EP system with Stereotaxis’ robotic magnetic navigation system.
The combination...
CathVision today announced its most recent financing round of US$9 million from investors.
The financing will help advance commercial operations driving adoption of the ECGenius...
AccurKardia has announced that its flagship product, the AccurECG analysis system has been granted US Food and Drug Administration (FDA) 510(k) clearance.
AccurECG is a...
FIRE1 has announced that the first US patients have been successfully implanted with its FIRE1 system for remote heart failure monitoring in an early...
Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator.
Investors include...
Sequana Medical NV has announced that the first patient has been enrolled in the MOJAVE study, a randomised controlled Phase 1/2a study in the...
Biotronik has announced US Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronisation therapy pacemaker (CRT-P).
In a...
Researchers have developed a soft, fully bioresorbable, transparent microelectrode array (MEA) for monitoring heart disease and dysfunction.
Outlining the design, fabrication, characterisation and validation of...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir dual chamber (DR) leadless pacemaker system, described by the...
Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according...
Anumana has received breakthrough device designation from the US Food and Drug Administration (FDA) for its electrocardiogram (ECG) artificial intelligence (AI) algorithm designed to...
Philips, a global leader in health technology, has announced it has teamed up with Biotronik, a leading global medical device company with products and...
BioCardia, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, has announced that the US Food and Drug...
Findings of a retrospective cohort study assessing the long-term real-world safety and efficacy of leadless pacemakers implanted in patients throughout the Netherlands are “promising...
Procedure-related complications and mortality rates associated with catheter ablation of atrial fibrillation (AF) are low and have declined in the past decade, conclude the...
CorWave has raised €61 million to fund its first industrial deployment and entry into clinical trials.
SPI fund, managed by Bpifrance on behalf of the...
Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first year while depression affects one in five,...
The European Society of Cardiology (ESC) has announced the appointment of Jean-François Riffaud as its new chief executive officer. Riffaud will replace Isabel Bardinet,...
Arrhythmia Alliance has announced the launch of the first SVT Awareness Day (7 June), taking place during World Heart Rhythm Week (5‒11 June) to...
The US Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernising the design...
Researchers have developed an artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
This approach can enhance...
Defibrillators are being used in just one in 10 cardiac arrests where they are available, according to research presented at the British Cardiovascular Society...
Conformal Medical has announced the successful completion of its series D funding round, raising a total of $35 million. The company is developing the...
Medtronic has announced that Ken Washington has been appointed chief technology and innovation officer.
Washington joins Medtronic from Amazon where he served as vice president...
Kardium has announced today that the first US patients have been successfully treated in the PULSAR clinical study, using its Globe pulsed-field ablation system.
The...
This article was sponsored by Biosense Webster
According to data published by Patrick M McCarthy (Feinberg School of Medicine, Chicago, USA) and colleagues in the...
New data presented from an investigator-sponsored European trial found managing indicated heart failure patients with Abbott’s CardioMEMS HF system resulted in a significant improvement...
Medtronic has announced US Food and Drug Administration market clearance to apply the AccuRhythm AI algorithms to the Reveal LINQ insertable cardiac monitor (ICM),...
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...
Preliminary results from the BIO-LIBRA study, assessing the outcomes of device-treated ventricular arrhythmias or mortality in patients with non-ischaemic cardiomyopathy (NICM) being treated with...
Findings from a new clinical trial support use of implantable cardiac monitors (ICM) as a standard of care in managing patients with complex cardiac...
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronisation therapy (CRT) among patients who were not able to be...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's TactiFlex Ablation Catheter, Sensor Enabled, which features a flexible...
A novel artificial intelligence (AI) model correctly identified patients at near-term risk of sustained ventricular tachycardia (VT) who could potentially benefit from preemptive interventions...
Results from a clinical trial, presented at the 2023 Heart Rhythm Society annual meeting (May 19–21, New Orleans, USA), indicate that overweight and obese...
New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
Medtronic has announced findings from a secondary analysis of the PULSED AF study, demonstrating positive results for the Medtronic PulseSelect pulsed field ablation (PFA)...
Stereotaxis has announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP system with Stereotaxis’ Robotic Magnetic Navigation system.
The combination of Abbott’s...
Late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess Abbott’s Aveir dual-chamber leadless pacemaker, have...
Impulse Dynamics has today announced the completion of the first implantation for the INTEGRA-D clinical trial, designed to evaluate the safety and efficacy of...
MicroPort, a global developer in the field of cardiac rhythm management, announced today it has received US Food and Drug Administration (FDA) approval for...
Biosense Webster—a stem of Johnson & Johnson MedTech—announced that data from the Q-FFICIENCY study was published in JACC: Clinical Electrophysiology. The study evaluated the...
A recent study has found deep neural networks (DDNs)—a category of artificial intelligence (AI) algorithm—capable of forecasting cardiac pump function from standard angiography videos,...
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the USA to reduce the risk of cardiovascular (CV) death, hospitalisation for heart failure (hHF) and urgent...
Biotronik announced today the latest addition to its cardiac rhythm management portfolio.
"We are excited to have received CE mark for our newest technology—the world’s...
Adagio Medical has announced the completion of enrolment in its Cryocure-VT trialof ultra-low temperature cryoablation for the treatment of monomorphic ventricular tachycardias.
Sixty patients with...
Medtronic has received US Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2 leadless pacemakers.
Micra AV2 and Micra VR2, the...
CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the electrophysiology (EP) lab, today announced initial patient enrolment of...
Results from the MATRIX study show that the high detection accuracy of DX single-lead implantable cardioverter defibrillator (ICD) systems for atrial fibrillation (AF) episodes...
Effective management of depression through psychological therapy is associated with a lower likelihood of heart disease and stroke, according to research published today in...
Medtronic have announced the 12-month findings that supported the Affera Mapping and Ablation system CE Mark, demonstrating that the Sphere-9 catheter can successfully treat...
Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without...
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation (AF) ablation, according...
An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation (AF)...
A novel software tool set to improve the management of elderly atrial fibrillation (AF) patients with multiple conditions is being designed by the EU-funded...
High power electric vehicle chargers are safe for patients with pacemakers and defibrillators, according to a study published in EP Europace, a journal of...
Spanish footballer, Iker Casillas, was awarded an European Heart Rhythm Association (EHRA) Gold Medal for services to cardiovascular health yesterday at the 2023 annual...
Thirty-day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking...
A region-wide study in more than 50,000 patients with atrial fibrillation (AF) has found reduced risks of stroke and transient ischaemic attack in those...
Stereotaxis has announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN) system.
Genesis RMN, was first used...
Boston Scientific has received CE mark for its POLARx FIT cryoballoon catheter for atrial fibrillation (AF) ablation.
According to the company, the device is the...
Daytime napping for 30 minutes or longer is associated with an increased likelihood of developing atrial fibrillation (AF), according to research presented at European...
Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new...
SentiAR has closed a Series B financing round worth US$8.5 million. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners...
Medtronic has announced the launch of MRI Care Pathway, a new system designed to streamline the process of completing magnetic resonance imaging (MRI) scans...
Endotronix has announced its PROACTIVE-HF pivotal study has successfully completed enrolment.
The study is designed to evaluate the safety and efficacy of the Cordella pulmonary...
Wearable devices such as smart watches could be used to detect a higher risk of developing heart failure and irregular heart rhythms in later...
The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have released an updated expert consensus statement on transcatheter left...
Results from the PADN-5 study, investigating the efficacy and safety of pulmonary artery denervation in the treatment of combined postcapillary and precapillary and pulmonary...
More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men, according to research presented at the...
Patients with atrial fibrillation (AF) have been said to benefit from early rhythm control therapy, which reduces cardiovascular deaths, strokes, and other adverse outcomes...
Procyrion, a medical device company which aims to improve outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix...
Abbott has today announced new data that found monitoring patients remotely with haemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can...
Vektor Medical has announced that use of the vMap arrhythmia mapping system during complex atrial fibrillation (AF) ablation was associated with significantly improved freedom...
Stereotaxis has announced the opening of a new robotic electrophysiology programme at Broward Health Medical Center in Fort Lauderdale, USA. Broward Health is among...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of...
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electrocardiogram (VECG) platform for heart attack detection today announced the strategic acquisition of...
Kardium, a private medical device company that has developed the Globe pulsed field (PF) system for the treatment of atrial fibrillation (AF) using pulsed...
Acesion, the biotech developing first-in-class novel therapies for atrial fibrillation (AF), has today announced positive data from its phase two trial of AP30663, a...
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...
A recent analysis of a large nationwide database of patients with atrial fibrillation (AF) who underwent ablation has reported an independent association between being...
A retrospective cohort study investigating the rate of maternal characteristics associated with, and survival following, cardiac arrest during delivery hospitalisation, has found that older,...
Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...
A recent study has provided new mechanistic insights identifying distinct atrial electrophysiological remodelling and fibrosis-associated conduction abnormalities favouring atrial fibrillation (AF) susceptibility in heart...
Biosense Webster has announced the first cases with its investigational Thermocool Smarttouch SF dual energy catheter have taken place as part of the SmartfIRE...
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical...
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation (PFA) treatment in patients with paroxysmal and persistent atrial fibrillation (AF), have been...
UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using Vivalink's Biometrics Data Platform. The study, consisting of 70...
Early rhythm control one year after atrial fibrillation (AF) diagnosis has been found to be beneficial in preventing recurrent stroke in patients with incident...
Massachusetts Institute of Technology engineers have created a soft robotics-enabled three-dimensional (3D)-printed anatomical hydrodynamic system that can recreate the hemodynamic system of aortic stenosis...
Biotronik has received CE mark approval for the Selectra 3D implant tools to include left bundle branch area pacing (LBBAP) in addition to His-bundle...
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent...
Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with...
CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex activation therapy for heart failure—postmarket randomised clinical trial.
The BeAT-HF postmarket phase of the multicentre,...
A new “red flag-raising” study has provided benchmark data on the safety of smart scales, watches and rings with bioimpedance technology for patients with...
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Medtronic has received CE mark for the Aurora extravascular implantable cardioverter-defibrillator (EV-ICD) magnetic resonance imaging (MRI) SureScan device and Epsila EV MRI SureScan defibrillation...
A retrospective analysis of randomised clinical trials has found that one in five patients aged 70 years or older with cardiovascular risk factors are...
Kareem Abdul-Jabbar is working with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AF) and its symptoms as part of the...
University of Texas (UT) Southwestern Medical Center researchers have mapped gene control elements in specialised cardiac cells responsible for heartbeat regulation. The findings of...
Acutus Medical has announced results from the AcQForce Flutter study, evaluating use of the AcQBlate Force sensing ablation catheter and system in the treatment...
GE HealthCare has signed an agreement to acquire Caption Health, a developer of artificial intelligence (AI)-driven ultrasound technology.
The Caption Health technology—Caption AI—has been developed...
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
Abbott has today announced receipt of the CE mark for the TactiFlex ablation catheter, sensor enabled (SE), alongside US Food and Drug Administration (FDA)...
Among patients with heart failure with preserved ejection fraction (HFpEF) and a pacemaker, treatment with a moderately accelerated, personalised pacing rate resulted in an...
AtriCure has announced that the first patient was treated in the LeAAPS clinical trial, a prospective, randomised clinical trial to evaluate the safety and...
Conformal Medical has announced the presentation of one-year data from the company’s initial left atrial appendage occlusion (LAAO) cases with its novel CLAAS system...
Researchers have found a correlation between periodontitis and fibrosis scarring to an appendage of the heart’s left atrium that can lead to atrial fibrillation...
The prospective cohort study of 626 patients with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) suggests said ICDs remain suitable to treat detected...
BioVentrix, a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated left ventricle and reverse...
tenacio, a company focused on digitising cardiovascular care to improve patient outcomes and reduce healthcare costs, has announced its OptiCor patient management platform is...
Varian, associated with Siemens Healthineers, announced today that the US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the pivotal...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...
Ra Medical Systems announces the completion of its previously-announced stock-for-stock merger transaction with Catheter Precision, a company focused on the cardiac electrophysiology market.
MedTech veteran...
Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its wearable remote patient monitoring devices have...
CardiacSense, a digital health company that developed the world's most advanced, medically certified wearable device for monitoring vital signs, announced receipt of US Food...
In their updated meta-analysis of 4,175 patients, Stergios Intzes together with a team from the Democritus University of Thrace, Alexandroupoli, Greece and the Heart...
HeartBeam, a cardiac technology company that has developed a 3D-vector electrocardiogram (ECG) platform for heart attack detection, has announced that a patent that enables...
A preclinical study demonstrating key features of the foam-based left atrial appendage closure device (CLAAS, Conformal Medical) has been published in the Journal of...
Cardiac Insight, a specialist in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has announced that researchers at...
Volta Medical has announced €36 million in new series B funding, bringing the total capital raised to over €70 million.
The company is developing artificial...
Anthos Therapeutics has announced that it has enrolled the first patient in LILAC-TIMI 76, a phase 3 study to evaluate the efficacy and safety...
Johnson & Johnson has today announced it has completed its acquisition of Abiomed. Abiomed is now part of Johnson & Johnson and will operate...
Primary care visits rise sharply in the weeks immediately preceding a sudden cardiac arrest, according to results from the ESCAPE-NET project. The project is...
A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical...
The current model for randomised clinical trials must be redesigned for the modern age, according to the European Society of Cardiology (ESC), American Heart...
Field Medical and CardioNXT have announced a strategic collaboration to provide the first-of-its-kind focal pulsed field ablation (PFA) therapy integrated with 3D mapping &...
Biotronik announce the first patient enrolment in BIO-CONDUCT, an US Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) trial examining the use...
With numerical simulations, researchers have demonstrated a new way to time weak electrical pulses that can stop certain life-threatening arrhythmias. Publishing their work in...
Based in the USA, Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake...
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin (Forxiga) in Great Britain...
The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to prevent a “shortfall of essential medical devices for...
Ultromics’ EchoGo Heart Failure, an artificial intelligence (AI) solution for echocardiography with the potential to revolutionise the diagnosis of heart failure with preserved ejection...
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....
A first-of-its-kind analysis on electrophysiological findings in patients with recurrent atrial tachyarrhythmia (ATa) following pulmonary vein isolation (PVI) using the novel pentaspline pulsed-field ablation...
More scientific evaluation is needed to develop and validate consensus recommendations to ensure that benefits will outweigh risks for consumers who use smartwatches in...
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...
An analysis of randomised controlled trials (RCTs) has found catheter ablation reduces mortality and heart failure hospitalisations in patients with atrial fibrillation (AF) and...
HeartBeam, a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection has announced that its...
Abbott has announced that Health Canada has approved the Aveir single-chamber (VR) leadless pacemaker.
The Aveir leadless pacemaker is implanted directly inside the heart's right...
A recent presentation by Paul J Wang (Stanford School of Medicine, Stanford, USA) at the American Heart Association (AHA) Scientific Session 2022 conference (5-7...
Biosense Webster has announced the publication of data from a study comparing the risk of dementia in patients with atrial fibrillation (AF) who were...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.
These were the...
WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an investigational study to evaluate the safety and efficacy of transcatheter...
Screening to detect atrial fibrillation (AF) in older people would not only increase the chance of preventing stroke, it would also save money for...
iRhythm Technologies has announced a new health economic analysis of the mSToPS study, presented at the American Heart Association (AHA) scientific sessions 2022 (5–7...
CathVision has announced the investigation of the Signal Complexity algorithm designed to visualise and quantify atrial fibrillation (AF) complexity parameters in patients with persistent...
Acutus Medical has announced that it has achieved the first milestone under the asset purchase agreement of its left-heart access portfolio with Medtronic.
This triggers...
Boston Scientific has announced the European launch of the LUX-Dx insertable cardiac monitor (ICM) system, a long-term diagnostic device inserted under the skin of...
Kardium has announced the successful first-in-human study of its next generation Globe pulsed field system to treat atrial fibrillation (AF) using pulsed field ablation...
Use of apixaban was associated with a lower risk of gastrointestinal bleed and similar rates of ischaemic stroke or systemic embolism, intracranial haemorrhage and...
Johnson & Johnson is to acquire Abiomed, it was announced today, after the two organisations entered into a definitive agreement under which Johnson &...
Adagio Medical has announced its first pulsed field cryoablation (PFCA) procedure performed using the Adagio CryoPulse catheter system as part of the PARALELL (Pulsed...
Researchers are to investigate the safety and efficacy of performing left atrial appendage occlusion in patients at high risk for atrial fibrillation (AF) who...
AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocardiogram (ECG) analytics, has announced it will collaborate with Mawi, a medtech provider of...
In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart disease, those receiving apixaban had a lower risk for ischaemic...
Medtronic has received US Food and Drug Administration (FDA) approval for expanded labelling for the SelectSecure Model 3830 cardiac lead for left bundle branch...
Catheter ablation of atrial fibrillation (AF) has favourable effects on cerebral blood flow, particularly in non-paroxysmal AF, research published in JACC: Clinical Electrophysiology.
The results...
Biosense Webster has announced the European launch of the Heliostar radiofrequency balloon ablation catheter. Heliostar is indicated for use in catheter-based cardiac electrophysiological mapping...
Vektor Medical has announced study results that demonstrate a reduction in total procedural duration, fluoroscopy use, and cost after implementation of vMap, its cardiac...
A real-world study of smartwatch electrocardiography (ECG) tools for the detection of atrial fibrillation (AF) has found that the use of such devices is...
Researchers have used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation (AF). In the digitally-enabled,...
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2022 Transcatheter Cardiovascular Therapeutics meeting (TCT, 16–19 September,...
This year marked the 20th edition of the Atrial Fibrillation Symposium (AFIB2022; 24–25 May, Copenhagen, Denmark) which, over its lifetime, has evolved to become...
Medtronic has announced that the Linq II insertable cardiac monitor (ICM) system has received 510(k) clearance from the US Food and Drug Administration (FDA)...
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatzer Amulet left atrial appendage occlusion (LAAO) device have shown continued safety and...
Implantable cardioverter defibrillator (ICD) information on YouTube is of low and highly-variable quality, according to research presented at the American College of Cardiology (ACC)...
A study in Circulation: Arrhythmia and Electrophysiology has identified new-onset atrial fibrillation (AF) in one in 20 patients hospitalised with COVID-19.
Using data from the...
A new report from the American Heart Association’s (AHA’s) National Cardiac Implantable Electronic Device (CIED) Infection Initiative aims to improve adherence to guidelines on...
Ra Medical Systems has entered into a merger agreement with Catheter Precision.
Under the terms of the agreement, Catheter Precision will become a wholly owned...
Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and Vascade MVP venous vascular closure systems.
The CE marking will allow...
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring system are being presented at the American Heart Association (AHA) Hypertension Scientific Sessions...
Biotronik has announced a partnership with AliveCor, the developer of personal electrocardiogram (ECG) technology and services.
The partnership will bring together Biotronik’s Biomonitor injectable cardiac...
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the...
Vektor Medical has announced the publication of a peer-reviewed manuscript of the clinical data from a study evaluating the accuracy of its vMap technology...
AtriAN Medical has announced that it has completed enrolment of a second study using its selective pulsed field ablation (PFA) technology for the treatment...
Biosense Webster has announced the release of the Octaray mapping catheter, developed for the mapping of cardiac arrhythmias including atrial fibrillation (AF). The catheter...
Boston Scientific has received US Food and Drug Administration (FDA) approval to expand the instructions for use labelling for the current-generation Watchman FLX left...
Data from the PROMET and RELEASE studies provide important new insights into the safety and efficacy of rotational transvenous lead extraction (TLE), Christoph Starck...
LifeTech has announced that a US Food and Drug Administration (FDA)-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre Plus left atrial appendage (LAA)...
The addition of posterior wall isolation (PWI) does not improve arrhythmia outcomes compared with pulmonary vein isolation (PVI) alone in patients undergoing first time...
Volta Medical has announced that peer-reviewed results from the company’s Ev-AIFib proof of concept study with its VX1 decision support software has been published...
Researchers have developed a risk score to predict mortality for patients with atrial fibrillation (AF) who have undergone a successful transcatheter aortic valve implantation...
Medtronic has announced that it has completed the acquisition of Affera. The acquisition will expand Medtronic’s cardiac ablation portfolio to include its first cardiac...
Galaxy Medical has announced that it received the CE mark for its Centauri pulsed electric field (PEF) system and launched its commercial programme.
The approval...
Medtronic has announced that its investigational EV ICD system—a defibrillator with the lead placed under the breastbone, outside of the heart and veins—achieved a...
Screening for atrial fibrillation (AF) using a smartphone app more than doubled the detection and treatment rate in older people compared to routine screening,...
Results of one of the first and only randomised, blinded trials to assess the use of an artificial intelligence (AI) algorithm as an assessment...
New guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have been published today in the European...
Merit Medical has announced the launch of its SafeGuard Focus Cool compression device.
It is part of a broader cardiac portfolio that offers products and...
Thermedical has announced that the US Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and...
Cannabis prescribed for chronic pain is associated with an elevated risk of heart rhythm disorders, according to research presented at the European Society of...
Patients with recently diagnosed atrial fibrillation (AF) with a high burden of comorbidities should be considered for early rhythm control to reduce cardiovascular outcomes,...
The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending KardiaMobile 6L for measuring cardiac QT interval in people having...
A new scientific statement from the American Heart Association (AHA) provides guidance about sleep-disordered breathing and its association with the development of cardiac arrhythmia.
Published...
CathVision has secured US$7.2 million in funding from existing investors to help advance commercial operations driving adoption of the ECGenius system, the company's EP...
A first-in-human multicentre trial using in-catheter, heated saline-enhanced radio frequency (SERF) ablation for patients with ventricular tachycardia (VT) has reported that the technique showed...
OSYPKA AG, a medical device company based in Rheinfelden, Germany, has received the CE mark under the European Union’s Medical Device Regulation (MDR) for...
The Heart Rhythm Society (HRS) has announced the full line-up of speakers and sessions for its first annual HRX meeting (8–10 September, San Diego,...
Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by 2060, a study published in the Journal of the...
A project to develop genetic therapies to effectively cure cardiomyopathy has been announced as the winner of the British Heart Foundation’s Big Beat Challenge,...
Adagio Medical has announced the publication of the results of its Cryocure-2 ultra-low temperature cryoablation (ULTC) study in patients with atrial fibrillation (AF) in...
InCarda Therapeutics has announced enrolment of the first patient in the company’s pivotal phase 3 RESTORE-1 clinical trial of InRhythm (orally inhaled flecainide) in...
Acutus Medical has announced approval of its AcQMap high resolution imaging and mapping system and the AcQMap 3D imaging and mapping catheter in Japan.
Acutus’...
iRhythm Technologies has received US Food and Drug Administration (FDA) 510(k) clearance for its ZEUS (Zio ECG Utilization Software) system for the Zio Watch.
Produced...
Acutus Medical has announced that David Roman has been appointed president and chief executive officer, and member of the Board of Directors, effective immediately....
Around 80% of patients diagnosed with atrial fibrillation (AF) in the UK population are eligible for early rhythm control, an analysis of the EAST-AFNET...
Boston Scientific is collaborating with Telefónica España to provide ‘advanced healthcare technology’, including 5G, through its recently launched Remote Clinical Support Centre—RhythmCARE—which is intended...
A research project at the University of Leeds (Leeds, UK) aiming to find an easier way to establish the optimum heart rate for heart...
Stereotaxis has announced the CE mark submission for its MAGiC catheter, a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures.
MAGiC...
Abbott has introduced its EnSite X EP a cardiac mapping platform with EnSite Omnipolar Technology (OT) in Canada.
The platform allows for the creation of...
Biotronik’s LiveSupport feature was used to remotely support two Biomonitor implantable cardiac monitor (ICM) implants shortly after launch. Both procedures were performed with a...
Catheter ablation of atrial fibrillation (AF) was economically attractive compared with drug therapy in the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial...
Cardiac testing company CardiNor AS has announced that it has signed an exclusive agreement with IBL-America for sales of the CardiNor Secretoneurin ELISA test...
HeartBeam is expanding the available patient population for its emergency department software technology solution. In evaluating the electrocardiogram (ECG) database for the clinical validation...
Acutus Medical has announced the completion of the first of two closings for its previously disclosed sale of the company’s left-heart access portfolio to...
People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted to hospital with heart failure, according to a study...
Acutus Medical has announced the commercial launch of an expanded suite of left-heart access products to now include the AcQCross Qx system for use...
In patients treated with pulsed field ablation (PFA) for symptomatic paroxysmal atrial fibrillation (AF), the incidence of asymptomatic thromboembolic cerebral events or lesions detected...
A study, published in the European Heart Journal–Digital Health, shows the predictive potential of a deep-learning model in identifying patients at risk of atrial...
Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe exercise have been published in the European...
A national, multicentre registry investigating the safety and efficacy of laser lead extraction has reported high success- and low procedure-related complication rates associated with...
Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of the first patients at two US sites.
The investigational device...
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman FLX (Boston Scientific) device was comparable in terms of rates of...
Incidence of ventricular arrhythmias can be linked to days when air pollution is high, according to research presented at Heart Failure 2022 (21–24 May,...
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the safety and effectiveness of AtriCure’s Isolator Synergy Clamp...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients...
A study has revealed the “global collateral damage” caused by the disruption to cardiac services caused by the COVID-19 pandemic. Writing in the European...
The use of a subcutaneous-implantable defibrillator (S-ICD, Boston Scientific) reduced the rate of major, lead-related complications by as much as 92% when compared to...
Findings of the US multicentre cardioneural ablation (CNA) registry were presented during a late-breaking clinical trial session at the Heart Rhythm Society’s 2022 annual...
Attune Medical has announced that the first patients have been enrolled in the IMPACT II— Improving Oesophageal Protection During Catheter Ablation for Atrial Fibrillation—study,...
inHEART has received US Food and Drug Administration (FDA) 510(k) clearance for its inHEART Models software suite that enables 3D visualisation and analysis of...
Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella pulmonary artery pressure sensor system in New...
Findings of the EAST-AFNET 4 trial, examining the benefit of early rhythm control therapy in patients with newly diagnosed atrial fibrillation (AF), should influence...
Results of a study presented at the Heart Rhythm Society’s 2022 annual meeting (HRS 2022, 29 April–1 May, San Francisco, USA) show that the...
Use of an artificial intelligence (AI)-based app using electrocardiogram (ECG) signals recorded with an Apple Watch is able to identify left-ventricular dysfunction, research presented...
CathVision has announced US Food and Drug Administration (FDA) 510(k) clearance of the ECGenius electrophysiology recording system. ECGenius acquires high-fidelity, low-noise, cardiac electrograms to...
Ceryx Medical has raised £3.8m in seed funding which will be used to commercialise its technology and commence the first-in-human clinical study of the...
The Heart Rhythm Society (HRS) has announced the findings of three clinical trials demonstrating positive outcomes of conduction system pacing (CSP) for patients in...
Results from a new clinical trial found aggressive blood pressure (BP) control reduced the risk of left-ventricular conduction disease. This study is the first...
Abbott has announced US availability of its Amplatzer steerable delivery sheath, which is used with the company's Amplatzer Amulet left atrial appendage (LAA) occluder...
Medtronic has announced new data from the STROKE AF clinical trial, showing that large and small vessel ischaemic stroke patients who receive short-term or...
CathVision has completed patient enrolment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center (Burlington, USA). The study...
Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...
The use of high-power, short duration ablation for atrial fibrillation (AF) has the potential to speed up procedural times and increase the number of...
The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring and management, including for patients with heart failure—and...
Medtronic has announced two AccuRhythm AI algorithms will be applied to LINQ II insertable cardiac monitors (ICM) through cloud-based updates in Europe later this...
Fitbit has received clearance from the US Food and Drug Administration (FDA) for a new photoplethysmography (PPG) algorithm to identify atrial fibrillation (AF). The...
Cardiologs has announced the results of a clinical study showing that its deep learning artificial intelligence (AI) software reduces inconclusive results returned by the...
Among the array of remote monitoring and digital arrhythmia management tools on display at the 2022 European Heart Rhythm Association annual meeting (EHRA 2022,...
FEops has announced that it received authorisation from the US Food and Drug Administration (FDA) for FEops Heartguide pre-operative planning of left atrial appendage...
iRhythm Technologies has announced the results of three clinical research studies presented at the American College of Cardiology’s annual scientific sessions (ACC 2022, 2–4...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients...
Screening for atrial fibrillation (AF) should be integrated into flu vaccination and cancer screening programmes, according to a survey of general practitioners (GPs) conducted...
A simple electrocardiogram (ECG) can pinpoint hospitalised COVID-19 patients at high risk of death who might need intensive management, according to the authors of...
Overweight patients with atrial fibrillation (AF) are more likely to experience a return of the heart rhythm disorder after a corrective procedure than those...
Results of a large-scale, real-world analysis of US Centers for Medicare & Medicaid Services (CMS) data on the rates of guideline adherence and associated...
Use of cardiac magnetic resonance (CMR) may relevant role of CMR in risk stratification for sudden cardiac death after myocardial infarction, to late-breaking research...
Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices has been published today in...
The “exponential growth” in the use of digital devices for monitoring arrhythmias has led to the development of a new international consensus document. The...
East End Medical has announced the first commercial use of its SafeCross transseptal radiofrequency (RF) puncture and steerable balloon introducer system. The system is...
The launch of the latest KODEX-EPD cardiac mapping and navigation system is among the features Royal Philips will showcase at the 2022 European Heart...
GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device...
Researchers have developed a clinical algorithm that distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
The findings, Journal of the American...
Black and Hispanic individuals experiencing a cardiac arrest either at home or in public are substantially less likely to receive cardiopulmonary resuscitation (CPR) from...
Researchers want to leverage the centuries-old art of cutting paper into designs to develop a sensor sheet that can stretch and breathe alongside the...
Stereotaxis has announced that Poland’s National Institute of Cardiology in Warsaw has established the first robotic electrophysiology programme in the country with Stereotaxis’ Genesis...
Research published in the journal BMC Medicine investigates the impact of kidney function in patients on antithrombotic therapy.
The study, a post hoc sub-group analysis...
Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...
A consensus document outlining design principles and outcome definitions for device-based therapies for hypertension has been published in the journal Circulation.
The development of the...
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
DiA Imaging Analysis Ltd, announced today a multi-year agreement with Change Healthcare. Change Healthcare's proven cardiology solutions, along with DiA's AI-based algorithms, will benefit...
A new strategy using telehealth to monitor blood pressure at home for several months immediately after a stroke had a positive impact on patient engagement and blood...
Hospitals in England are trialling remote monitoring technology from iRhythm Technologies—Zio XT—which is designed to aid the detection of arrhythmias supported by artificial intelligence.
Typically...
Royal Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first-line diagnostic ambulatory monitoring solution with post-cryptogenic stroke patients.
The study...
As a result of the COVID-19 pandemic, the increasing uptake of paediatric electrophysiology (EP) telehealth services has demonstrated clear ability to deliver healthcare for...
Portable electronic devices containing magnets may inhibit pulse generators for implanted cardiac devices (ICDs) and pacemakers according to new research published in Circulation: Arrhythmia...
A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientific) left atrial appendage closure (LAAC) demonstrated a low rate of...
Women remain underrepresented in leading cardiovascular clinical trials, corresponding with underrepresentation and a lack of gender diversity among presenters at scientific meetings, according to...
Wearable technology and digital health specialist Activinsights has announced a partnership agreement with the cardiovascular research organisation Cardialysis to promote the use of remote...
A review paper published in JACC: Clinical Electrophysiology explores the potential mechanisms linking stress and atrial fibrillation (AF), and the possible uses of stress...
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have failed to respond to, or tolerate antiarrhythmic drug therapy, electrophysiologist Dhiraj...
Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with detectors optimised in size for integrated use in the cath lab.
The...
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indication for the company’s CardioMEMS HF system to support...
Medtronic has announced that the Freezor and Freezor Xtra cardiac cryoablation catheters are approved by the US Food and Drug Administration (FDA) to treat...
Fewer than half of UK citizens are aware of the link between arrhythmia and stroke, while around one in five people with a personal...
Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food and Drug Administration (FDA). Califf returns to the role...
A new timely practice—known as the “1-2-3-4-day” rule—for the administration of direct oral anticoagulants (DOACs) in patients after acute ischaemic stroke or transient ischaemic...
Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a company that offers advanced transseptal access solutions as well as...
Vektor Medical has announced that the University of California, San Diego Health (UCSD, San Diego, USA) is the first hospital system to offer the...
CoreMap has announced the closure of a US$3 million series A milestone financing, with a US$20 million series B financing, which includes a diverse...
A collaboration between Ceryx Medical Limited and the scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, have developed...
atHeart Medical has announced that it has received US Food and Drug Administration (FDA) approval for the start of the second phase of its...
The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not reduce the total rate of heart failure events in a population...
Abbott has announced the first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The...
BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CardiAMP cell therapy system for the...
A same-day discharge strategy for left atrial appendage occlusion (LAAO) could become the standard approach for this technique, according to the authors of a...
AliveCor has announced the launch of KardiaMobile Card—an electrocardiogram (ECG) device the size of a standard credit card.
“After disrupting traditional ECG monitoring with our...
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.
As...
Royal Philips has announced the introduction of a full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralised clinical trials. The clinical-grade solution is...
A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...
Contact-force (CF)-guided ablation to treat typical atrial flutter does not reduce recurrent atrial arrhythmia at 12 months follow-up, in comparison to ablation blinded for...
Acute alcohol consumption is associated with a higher risk of atrial fibrillation (AF), a study published in Nature Cardiovascular Research has concluded
The study is...
Royal Philips is supporting the American Heart Association’s (AHA’S) effort to generate awareness among cross-disciplinary specialties and improve survival rates from cardiovascular implantable electronic...
According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...
MicroPort CRM has recently received the pharmaceuticals and medical devices agency (PMDA) Japanese regulation agency approval for the Alizea range of portable pacemakers. The...
Abbott has received clearance from the US Food and Drug Administration (FDA) for the EnSite X EP system with EnSite Omnipolar Technology (OT), a...
Medtronic has received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra AV Transcatheter Pacing System...
Medtronic has announced that it has entered into an agreement to acquire medical technology company Affera.
Affera designs and manufactures cardiac mapping and navigation systems...
Khaldoun Tarakji, associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic (Cleveland, USA) has joined Medtronic as...
The National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile (AliveCor) as an option for detecting atrial...
Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for an amendment to the company's PROACTIVE-HF study, a pivotal...
Adagio Medical has announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF).
The cases were performed at Medicover Hospital,...
Volta Medical has announced the introduction of VX1 artificial intelligence (AI) software at three US hospitals. New York Presbyterian Queens, Northwell Health’s Lenox Hill...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...
Affera has announced that the first patient was treated in the recently approved SPHERE PerAF trial, a US Food and Drug Administration (FDA) Investigational...
FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating versus Measuring Plasma Volume and Kidney Function in Acute Decompensated...
Kardium has announced the completion of successful first-in-human (FIH) procedures with the Globe pulsed field system.
Vivek Reddy of Mount Sinai Hospital (New York, USA)...
Implicity has announced US Food and Drug Administration (FDA) clearance for a novel medical algorithm that analyses ECG data from implantable loop recorders (ILRs).
“This...
LifeTech Scientific Corporation has announced that it has extended its agreements with Medtronic to further the strategic collaboration on the HeartTone domestic pacemaker project...
Stereotaxis has announced the publication of the results of a prospective, multicentre study comparing the incidence of silent cerebral embolism (SCE) in atrial fibrillation...
New research suggests that implantable cardioverter defibrillators (ICDs) are not used as frequently for females and patients of colour, despite the increased use of ICDs...
Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and features for cardiology, designed to “increase diagnostic confidence and...
SyMap Medical has announced the completion of a financing round which will be used to accelerate global clinical trials for the company’s renal mapping...
One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the results of a survey published online...
Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand, a breakthrough treatment for patients suffering from congestive heart failure. The...
Boston Scientific has announced the start of the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM modular therapy...
Persistent opioid use following a cardiac implantable electronic device (CIED) procedure is common, according to a study published in Circulation, which reports that 12%...
Canon Medical has announced the introduction of the Precise IQ Engine (PIQE) deep-learning reconstruction (DLR) and SilverBeam filter.
PIQE, which Canon describes as super-resolution deep-learning...
Acutus Medical has announced the initiation of AcQForce PFA-CE, a clinical study that will evaluate the safety and performance of the company’s focal force...
Cardiologs announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to use its AI-powered cardiac diagnostics platform for...
The advent of pulsed field ablation (PFA) will revolutionise the treatment of atrial fibrillation (AF), Tom de Potter (Aalst, Belgium) tells Cardiac Rhythm News,...
European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic has been published in the European...
Cardialen has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) to begin a clinical trial of...
Women diagnosed with breast cancer are significantly more likely to develop atrial fibrillation (AF) compared to women without cancer, according to research published in...
Results of the Fitbit Heart study, presented during a late-breaking science session at the American Heart Association’s Scientific Sessions 2021 (AHA 2021; 13–15 November;...
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-assisted One Click magnetic resonance imaging (MRI) acquisition software on...
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November, virtual), Cardiac Rhythm News speaks to the meeting’s programme committee...
Data from the global Leadless II IDE study evaluating the Aveir (Abbott) leadless pacemaker in patients with certain abnormal heart rhythms show that the...
Adults with type 1 or type 2 diabetes and atrial fibrillation (AF) are less likely to notice irregular heartbeat symptoms, more likely to have...
Caption Health and Ultromics have announced a strategic partnership to accelerate cardiovascular disease detection and treatment for more patients in more accessible care settings....
Vektor Medical has announced US Food and Drug Administration (FDA) 510(k) clearance for its novel computational electrocardiogram (ECG) mapping system, vMap.
vMap is designed to...
Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospital discharge than those who had a...
Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across its operations and value chain to accelerate efforts...
Royal Philips has signed an agreement to acquire Cardiologs, a developer of cardiac diagnostics using artificial intelligence (AI) and cloud technology. Cardiologs will further...
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 November, Orlando USA and virtual), comparing the Amulet...
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs) for the prevention of major cardiovascular, neurological or bleeding events in patients with...
South Korean artificial intelligence (AI) developer Vuno has announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company's AI-based...
Researchers from Massachusetts General Hospital (MGH, Boston, USA) have reported the detection and characterisation of thrombosis using fibrin-targeted positron emission tomography and magnetic resonance...
Research presented at the American College of Rheumatology’s annual meeting (ACR Convergence, 3–9 November, virtual) shows that hydroxychloroquine does not appear to be associated...
A pragmatic clinical trial—CHANGE AFib—will determine whether early treatment with the antiarrhythmic drug dronedarone improves cardiovascular and long-term outcomes in patients presenting with first-detected...
CathVision has announced the first patient enrolments in the PVISION multicentre clinical study, investigating the automated assessment of pulmonary vein isolation (PVI) using the...
An artificial intelligence (AI)-based computer algorithm created by researchers at the Mount Sinai Health System (New York, USA) has been able to learn how...
Ethnic and racial minority cardiologists report career satisfaction but face professional discrimination and exclusion. This was the main finding of the American College of...
Stereotaxis has announced publication of a study in the International Journal of Cardiology: Heart & Vascular demonstrating superior safety and efficacy of Stereotaxis’ robotic...
Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific.
The acquisition, for an upfront payment of US$1.75 billion, subject...
Medtronic has announced the publication of a study demonstrating, through the use of a continuous rhythm monitoring device, that atrial fibrillation (AF) is directly...
Haemonetics Corporation has announced that the Vascade MVP venous vascular closure system is has received a US Food and Drug (FDA) indication for same-day...
The US Food and Drug Administration (FDA) has informed healthcare providers of recent information about the potential for differences in procedural outcomes between women...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Amplatzer Talisman PFO Occlusion System to treat people with...
Biosense Webster, part of the Johnson & Johnson Medical Devices Companies has announced post-approval procedures were successfully performed with the Heliostar radiofrequency balloon ablation...
Benjamin D’Souza, assistant professor of Medicine at the University of Pennsylvania, cardiac electrophysiologist at Penn Presbyterian Medical Center, Philadelphia, USA, discusses the recent developments...
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—has been rescheduled to September 2022. The event had been due to...
Specific and dynamic changes on electrocardiograms (ECGs) of hospitalised patients with COVID-19 or influenza can help predict a timeframe for worsening health and death,...
Continuous heart rhythm monitoring—with anticoagulation if atrial fibrillation (AF) is detected—does not prevent strokes in those at risk. That is the finding of the...
Ablation plus cardiac resynchronisation therapy (CRT) is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent atrial fibrillation (AF) patients with...
Image-guided fibrosis ablation in addition to pulmonary vein isolation (PVI) does not improve ablation success rates compared to PVI alone in patients with persistent...
The Arrhythmia Alliance’s 2021 Heart Rhythm Congress (A-A HRC 2021 3–6 October, virtual) returns for its second ever digital edition, which will see more...
Galaxy Medical announced today the initiation of the SPACE-AF study with enrolment of the first two patients at Southlake Regional Health Centre in Newmarket,...
QardioDirect, the all-inclusive service for remote patient monitoring (RPM) from Qardio, now includes ambulatory cardiac monitoring to help diagnose atrial fibrillation (AF) along with...
VitalConnect has announced the launch of a new version of VistaCenter for cardiac and remote patient monitoring. This new version brings updates including simplified...
Medtronic has announced a pilot programme with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA), a condition...
Zoll Medical and Itamar Medical have announced that the two companies signed a definitive agreement under which Zoll Medical will acquire all outstanding ordinary...
Biotronik has announced the first observational results of the CERTITUDE registry, documenting real-world clinical outcomes of patients in the USA who use implantable loop...
Stereotaxis and Shanghai Microport EP Medtech have announced a broad collaboration to advance technology innovation and commercial adoption of robotics in electrophysiology in China.
The...
Bhargav Vemulapalli, Shreya Srivastava and John Kassotis (New Brunswick, USA) review the potential use of antibiotic-eluting envelopes (ABEs) based on available clinical data, while...
AliveCor has announced the results of what it describes as the largest study to assess the reliability of the detection of atrial fibrillation (AF)...
Cardiomatics, the cloud AI tool that allows any trained medical staff to carry out electrocardiogram (ECG) analysis, has raised US$3.2 million in seed funding...
Edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients with atrial fibrillation after transcatheter aortic valve implantation (TAVI), new...
Medtronic has announced new data from the Micra Coverage with Evidence Development (CED) study, which showed the Micra transcatheter pacing system (TPS) was associated...
Biosense Webster, part of the Johnson & Johnson Medical Devices Companies, has announced the presentation of data from the inspIRE clinical trial at the...
The European Society of Cardiology (ESC) Guidelines on cardiac pacing and cardiac resynchronisation therapy (CRT) have been published online in European Heart Journal.
The use...
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, head-to-head study comparing the company's Amplatzer Amulet left atrial appendage...
Abbott has announced results of the landmark GUIDE-HF clinical trial, a 1,000 patient randomised study designed to assess the benefits of the CardioMEMS HF...
The world’s first feasibility study has found that drones can be used to deliver defibrillators to people with suspected cardiac arrest in the community....
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published online today in European...
A six-month exercise programme helps maintain normal heart rhythm and reduces the severity of symptoms in patients with atrial fibrillation (AF), according to late-breaking...
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has raised US$33 million in a Series B funding round. The...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed’s Impella ECP expandable percutaneous heart pump. The designation means the...
CardioNXT has received marketing clearance from the US Food and Drug Administration (FDA) for the platform technology comprised of the iMap 3D Navigation &...
Biotronik has announced the results from a new study published in EP Europace this week confirming that heart failure (HF) decompensation can be predicted...
People who work night shifts are at increased risk of developing atrial fibrillation (AF), according to research published in the European Heart Journal.
The study...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Amplatzer Amulet Left Atrial Appendage Occluder to treat people...
Acutus Medical has received US Food and Drug Administration (FDA) and CE mark clearance for its suite of software upgrades known collectively as AcQMap...
Long-term continuous electrocardiogtraphy (LT-ECG), coupled with oversight by a physician, significantly outperforms algorithm-dependent mobile cardiac telemetry (MCT) in the detection of significant arrhythmias according...
Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have approved new technology add-on payments (NTAP) for the Caption Guidance...
Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broader inclusivity. This is according to two reports, both published in the last...
The challenge of rapid detection and diagnosis of atrial fibrillation (AF) has been made even harder with the onset of the COVID-19 pandemic, and...
Economic analyses from the WRAP-IT study, sponsored by Medtronic, demonstrate the Tyrx cardiac absorbable antibacterial envelope’s (Tyrx Envelope) cost effectiveness in European markets for...
Rhythm control therapy offers a clinical benefit when initiated within one year of a diagnosis of atrial fibrillation (AF) in patients with signs or...
A new analysis of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation) suggests that catheter ablation offers positive economic outcomes compared...
Results of the PAUSE-SCD trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalisation, and death when catheter ablation is...
Use of direct oral anticoagulants (DOACs) in patients undergoing ventricular tachycardia radio frequency ablation (RFA) is associated with a reduced risk of transient ischaemic...
Abbott has announced the US launch of Jot Dx, the company’s latest insertable cardiac monitor (ICM). In a press release, Abbott said that the...
Medtronic has announced US Food and Drug Administration (FDA) clearance for two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor...
AliveCor and Acutus Medical will collaborate to assess the integration of data collection tools across the cardiology continuum of care, which the companies say...
Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of its The Guardian device. The procedure marks the Guardian's first...
Affera has announced the first-in-human use of its circumferential pulmonary vein isolation (PVI) pulsed field ablation (PFA) catheter, SpherePVI.
The work was conducted as part...
MicroPort Cardiac Rhythm Management (CRM) has entered into definitive agreements in connection with its Series C financing with total investment proceeds of US$150 million.
Hillhouse...
Medtronic has announced new data from the WRAP-IT study published in Heart Rhythm, which it said demonstrate a significantly lower infection risk for patients...
People who made even small increases in their daily physical activity levels after receiving an implantable cardioverter defibrillator (ICD) experienced fewer incidences of hospitalisation...
There is no evidence that moderate coffee consumption can cause cardiac arrhythmia, according to the authors of a prospective, population-based community cohort study, findings...
Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation Watchman FLX (Boston Scientific) left atrial appendage closure...
Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelerate the CORCINCH-HF pivotal clinical study of the...
The authors of research published in JACC: Clinical Electrophysiology claim that their findings will help physicians to identify, treat and prevent atrial fibrillation (AF)...
atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ASD US Investigational Device Exemption (IDE) pivotal trial. This...
AliveCor has today announced the receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for healthcare professionals to use the KardiaMobile...
East End Medical has announced it has received US Food and Drug Administration (FDA) clearance for the company's SafeCross transseptal radiofrequency (RF) puncture &...
Among racial or ethnic minority patients enrolled in the North American cohort of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation)...
Fred Kusumoto (Jacksonville, USA), current president of the Heart Rhythm Society (HRS), sits down with Cardiac Rhythm News to discuss the upcoming Heart Rhythm...
Adagio Medical has announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic ventricular tachycardia (VT).
The two-hour mapping and ablation...
Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography (ICE) catheter. The left atrial appendage occlusion (LAAO) procedure was carried...
The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of the messenger RNA (mRNA) vaccine, according...
Boston Scientific has exercised its option to acquire the remaining shares of Farapulse. The acquisition will complement the existing Boston Scientific electrophysiology portfolio to...
Medtronic has announced the initiation of DEFINE AFib, an app-based research study which aims to address unanswered questions around atrial fibrillation (AF) burden and...
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the second-generation AngelMed Guardian device. The AngelMed Guardian system is...
The American Heart Association (AHA) has this week issued a scientific statement on the management of atrial fibrillation (AF) in patients with heart failure...
CardioFocus has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company's HeartLight X3 System for marketing in Japan....
Medtronic has received US Food and Drug Administration (FDA) expanded approval for the Arctic Front family of cardiac cryoablation catheters for the treatment of...
The Heart Rhythm Society (HRS) has announced the appointment of Simintha Esson as its new chief strategy officer (CSO).
In this role, Esson is responsible...
The president of the European Society of Cardiology (ESC) has called for greater awareness of the signs of cardiac arrest and how to respond,...
Imperial College Healthcare NHS Trust (London, UK) is working with remote healthcare developer, Luscii, to provide an at-home monitoring platform to support patients with...
MicroPort CRM has announced the European launch of Alizea and Borea pacemakers after receiving the CE mark under the new Medical Device Regulation. The...
Robert Kowal is the chief medical officer of the Cardiac Rhythm businesses at Medtronic. In this interview he shares his views and experiences on...
A campaign by Arrhythmia Alliance to DETECT atrial fibrillation (AF)—the most common type of arrhythmia—found that 6% of people aged 65 or older attending...
Among patients with both heart failure and atrial fibrillation (AF), treatment strategies focused on rhythm control, using catheter ablation, and those focused on rate...
A new physiological measurement of heart function could improve survival for people with heart failure by identifying high-risk patients who require tailored treatments, a...
GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for...
Medtronic has announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ insertable cardiac monitor (ICM) to detect...
Abbott has announced it has received CE mark and Health Canada approval for its Amplatzer steerable delivery sheath, which is used with the company's...
Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the company notified physicians to cease new implants of the...
Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracardiac echocardiography) catheter, an imaging guide that provides real-time,...
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA...
Implicity has announced a distribution agreement with MicroPort CRM, through which MicroPort CRM can sell and distribute Implicity's cloud-based solution in the USA as...
Physical activity that conforms to medical and health association guidelines is associated with a lower risk of atrial fibrillation (AF) and stroke, according to...
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021).
The Regulation revises quality and safety standards and the range...
iRhythm Technologies has announced two US Food and Drug Administration (FDA) 510K clearances—one for a new and improved design of its flagship monitor and...
Cardiomatics and the Medical University of Warsaw, Warsaw, Poland are developing a tool for automatic assessment, analysis, and interpretation of electrocardiographic signals (ECG) from...
The US Food and Drug Administration (FDA) has issued advice to patients with implanted devices such as pacemakers or implantable defibrillators to take precautions...
The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemic, according to research presented at the American College of Cardiology’s 70th...
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device was associated with a low rate of stroke at one year, even...
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much less likely to suffer a stroke after undergoing...
An electrocardiogram (EKG)-based artificial intelligence (AI) algorithm based can enable the early diagnosis of low ejection fraction in patients in routine primary care, according...
Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...
Acutus Medical has announced CE mark approval for a broad suite of electrophysiology (EP) products including the AcQCross family of universal transseptal crossing devices,...
Discrimination and harassment are a common experience among those working in cardiology, according to the findings from a global survey carried out by the...
Galaxy Medical (Galaxy) and Japan Lifeline (JLL) have announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the USA, developed by Japan...
A significant proportion of cardiology trainees are uncomfortable with using telemedicine and feel that better preparation for new-tech medicine is needed, findings of a...
Abbott has announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AF) and heart failure.
The TAP-CHF trial...
Subcutaneous implantable cardioverter defibrillator (S-ICD) devices have demonstrated a cardioversion efficacy rate of 98% over a period of at least five years in the...
AtriCure has announced US Food and Drug Administration (FDA) approval of the EPi-Sense system to treat patients diagnosed with long-standing persistent atrial fibrillation (AF).
The...
Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease...
Further efforts should be made to increase participation in atrial fibrillation (AF) screening—particularly in elderly populations, where systematic screening for AF can help to...
Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for anxiety and depression, according to research presented at the European Heart Rhythm...
A smartphone-based electrocardiogram (ECG) screening accurately detected previously unknown atrial fibrillation (AF) in American Indians, and more than half who were diagnosed were younger...
Atrial fibrillation (AF) could be detected during annual foot assessments in patients with diabetes, according to research presented today at the European Heart Rhythm...
This article was sponsored by Biosense Webster
Putting the patient at the centre of the discussion is vital to setting the right strategy for the...
A project at Oxford University Hospitals NHS Foundation Trust (Oxford, UK) to test how effective smart devices are at detecting heart rhythm problems has...
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family of universal transseptal crossing devices. The transseptal puncture system...
Cardialen has announced the publication of a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology investigating its low-voltage MultiPulse...
The charity Arrhythmia Alliance has launched the Arrhythmia Alliance Healthcare Pioneers Report—Showcasing Best Practice in SVT to provide examples of good care to improve...
More patients, particularly those with medical risk factors or from underserved communities, opted into telehealth appointments for their cardiovascular care during the COVID-19 pandemic,...
AF Association has launched an opportunistic screening programme to DETECT atrial fibrillation (AF) at COVID-19 vaccination clinics across the UK. The charity has created...
The American College of Cardiology (ACC) has launched the EP Device Implant Registry, which will include data on ICD and CRT-D procedures previously captured...
Acutus Medical has announced initial US enrolment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. The trial is expected to enrol...
Dipti Itchhaporia has today begun her term as president of the American College of Cardiology (ACC). During her one-year presidency, she will lead the...
Patients with valvular atrial fibrillation (AF) who were new users of direct oral anticoagulants (DOACs) were at lower risk for ischaemic stroke or systemic...
More than a third of female cardiologists polled in a UK survey on discrimination and sexism in the profession have reported receiving unwanted sexual...
Tempus has announced that the US Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG analysis platform. The...
Daiichi Sankyo has announced that it has entered into a collaborative agreement with three technology partners—FibriCheck, neoHealthTech and Capitol Medicare—to improve timely detection and...
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for mavacamten, an investigational,...
Higher procedural volume is associated with better outcomes for percutaneous left atrial appendage occlusion (LAAO) procedures, research published online in JACC: Cardiovascular Interventions has...
An assessment method known as the index-beat approach could improve the diagnosis of heart failure in patients with atrial fibrillation (AF), authors of a...
Medtronic has announced CE mark approval for the SelectSite C304-HIS deflectable catheter system, as well as CE mark labelling expansion for the SelectSecure MRI...
Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...
Qardio has announced that the US Food and Drug Administration (FDA) has granted the company 510(k) clearance for its QardioCore ambulatory ECG device. QardioCore...
Five-year follow-up results from the Gore REDUCE study, assessing the Gore Cardioform or Helex septal occluder versus antiplatelet therapy in long-term recurrent stroke prevention,...
The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials to be presented at its 70th annual scientific session...
CorSystem has announced the first use of its Bipolar Ablation Adapter since the device received CE mark in July 2020.
The patient who underwent treatment...
Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found. The study, led...
ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select, a technology that utilises proprietary semi-transparent filters, a user-interface...
